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ABSTRACT
Cell:cell interactions are critical at all stages of the immune response, yet
relatively little is known about their dynamics in vivo. We set out to visualize in intact,
living lymphoid tissue the physiological role of dendritic cells in tolerance and immunity;
this was achieved by intravital microscopy of fluorescently-labeled DCs and lymphocytes
in the inguinal lymph nodes. We generated mice that specifically expressed EYFP in their
dendritic cells and observed their behavior in living LNs; we found that in the steady
state, DCs formed sessile networks and largely restricted their movements to probing
with their dendrites. We next observed dendritic cells’ interactions with transferred
fluorescently labeled T cells under conditions of tolerance and immunity, and found both
were characterized by similar activation, proliferation, and early antigen-dependent T cell
arrest. Based on our initial observation that early tolerogenic and immunogenic
interactions are similar, we investigated the role of TCR affinity for MHC:peptide
complexes (pMHC) in these interactions during tolerance induction. We observed that
pMHC potency correlates with T cell proliferation, Ca2+ flux and with early antigenspecific arrest; T cell anergy was induced by all ligands that activated T cells, and was
independent of T cell proliferation, Ca2+ flux, and early arrest in vivo. We further
examined the in vivo dynamics of germinal center reactions, and observed that germinal
centers are dynamic structures, with nearly all GC B cells remaining motile and restricted
to the germinal center, migrating bidirectionally between dark and light zones. Follicular
B cells passed through the GC compartment easily, and were able to join ongoing GC
reactions in an affinity-dependent fashion.
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CHAPTER 1. INTRODUCTION

The immune system has fascinated people since antiquity. The first written
description of immune memory is from Thucydides, describing the plague of Athens in
430 B.C.: those people who recovered from the plague, himself included, could care for
the sick without becoming ill again (Thucydides and Warner, 1954). Inflammation was
recognized as a response to illness not long after, and the cardinal signs were described
by Celsus in the first century A.D.: rubor (redness), tumor (swelling), calor (heat), and
dolor (pain) (Celsus and Spencer, 1938). Since immune responses were recognized, the
question of how the body could tell self from non-self has been the primary focus of
immunology.
Much of the interest in immunology has been due to its obvious immediate
clinical applications, such as vaccination. From the time of Edward Jenner’s smallpox
vaccine, nothing was known about the mechanism by which hosts were protected until
Behring and Kitasato demonstrated antitoxins against diptheria. Although Metchnikoff
showed that macrophages could phagocytose bacteria, it proved too difficult to “stimulate
the phagocytes”, (Shaw, 1906), and cellular immunity fell out of favor, as the humoral
theories proved themselves with antisera.
One of the fundamental conceptual leaps in immunology was made by Karl
Landsteiner, with the discovery that antibodies could be generated to chemically
synthesized organic molecules if they were attached to a protein carrier. If the immune
system can specifically recognize arbitrary, synthetic molecules that have not previously
existed in nature, then antigenic space is not inherently limited to pathogens, which
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implies that the immune system is capable of generating reactions against self as well as
non-self. The rarity of autoimmunity implies a strong suppression of reactivity against
self antigens, something noted by Paul Erlich in his writings marveling that the body
manages to avoid a “horror autotoxicus” (Himmelweit, 1956-1960).
The mechanism of immune specificity was controversial, with arguments being
made for both “instructive” and “selective” theories. In the former, the antigen served as
a template for the folding of antibody; antibodies obtained specificity from their
interaction with antigen. The selective theories postulated that specific antibodies were
formed and reaction with antigen stimulated the production of that antibody. The bestformulated selective theory was Ehrlich’s “side-chain” theory, which said that “side
chains” were preformed and secreted in response to antigen. As people found it difficult
to conceive that the body could have preformed antibodies against chemically
synthesized molecules that did not previously exist in the environment, instructive
theories became more accepted, and selective theories were largely ignored, until the
question of self-tolerance was raised by Medawar’s experiments showing transplantation
tolerance (Billingham et al., 1953).
As self-tolerance came into focus, selective theories seemed more reasonable.
Niels Jerne put forth a reformulation of Ehrlich’s side-chain theory (Jerne, 1955), which
was expanded on by David Talmage (Talmage, 1959) and Macfarlane Burnet (Burnet,
1959). Burnet most clearly formulated the theory of clonal selection, which which
postulated that immune cells each expressed one unique, randomly-generated receptor,
that cells are only active after encountering their cognate antigen, and that self-reactive
clones are deleted during development (Burnet, 1959). Others contributed to the
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formulation of this theory as well, with Joshua Lederberg proposing “random assembly
of the DNA of the globulin gene during certain stages of cellular proliferation”
(Lederberg, 1959); this was proven correct seventeen years later, with the demonstration
that antibody diversity is generated somatically, through recombination (Brack et al.,
1978; Hozumi and Tonegawa, 1976).
The general paradigm of self and non-self does not completely describe the
immune system, however. Charles Janeway observed that the adaptive immune response
has evolved to protect its host from pathogenic non-self, and postulated that receptors
existed that could distinguish pathogenic molecules from non-pathogenic molecules
(Janeway, 1989): as the non-self molecules that threaten the host are pathogens, there
must be some way to differentiate between pathogenic non-self and irrelevant non-self.
This idea of pattern recognition receptors was proven right shortly thereafter with the
discovery that Drosophila toll is necessary for defense against fungi but not bacteria
(Lemaitre et al., 1996). The first mammalian innate receptor to be functionally
characterized was toll-like receptor 4 (TLR4), which recognizes lipopolysaccharide, a
component of the cell wall of gram-negative bacteria (Hoshino et al., 1999; Poltorak et
al., 1998; Qureshi et al., 1999). Since then, the critical importance of a second, antigenindependent, pathogen-derived signal in initiating immune responses has become more
evident (Janeway and Medzhitov, 2002); it is now known that TLRs are just one of the
signaling mechanisms by which pathogens are detected (Gavin et al., 2006; Inohara and
Nunez, 2003).
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Initiation of adaptive immune responses
Adaptive immune responses begin with antigen presentation to naïve T cells in
the lymph node paracortex; dendritic cells engulf antigenic particles and degrade proteins
into short peptides which are presented on MHC class I and II molecules (Itano and
Jenkins, 2003). Some reports have suggested that the extent of antigen processing and
presentation by DCs is influenced by TLR-mediated pathogenicity sensing (Blander and
Medzhitov, 2004; Blander and Medzhitov, 2006), but this remains controversial, as these
experiments were done in vitro and conflict with much in vivo data showing that DCs
constantly process and present self antigens to T cells in the draining lymph
node(Scheinecker et al., 2002; Steinman et al., 2003b; Wilson et al., 2004). DCs from
gastric LNs were found to present peptides from gastric parietal cell H+/K+ ATPase,
while DCs from skin-draining and mesenteric LNs did not, indicating that DCs present
endogenous self-antigens in non-inflammatory conditions in vivo (Scheinecker et al.,
2002). Subsequently, immature, endogenous DCs were shown to process and present
membrane-bound antigen to transgenic T cells, in the absence of any inflammatory state
(Wilson et al., 2004). Furthermore, numerous studies delivering antigen to multiple
endocytic receptors on DCs has demonstrated that antigen is processed and presented to
T cells efficiently in the absence of any priming stimulus (Bonifaz et al., 2002; Dudziak
et al., 2007; Hawiger et al., 2001; Idoyaga et al., 2008). The inconsistency between these
studies and the in vitro data may be due in part to differences between bone-marrow
derived macrophages and DCs in vitro and the physiological setting of intact lymphoid
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organs, with multiple subtypes of dendritic cells, other immune cells, stromal cells, and a
more diverse cytokine milieu.
Naïve T cells require more than antigenic stimulation through their TCR (“signal
1”) to generate immune responses; in the absence of T cell CD28 signaling (“signal 2”,
mediated through costimulatory molecules such as CD80 and CD86 on APCs), naïve T
cells are anergized (Bretscher and Cohn, 1970; Janeway, 1989; Jenkins et al., 1987;
Lenschow et al., 1996). The upregulation of costimulatory molecules on APCs is rapidly
induced by innate responses, including TLRs (Medzhitov et al., 1997); this prevents nonpathogenic antigens from inducing potentially harmful immune responses.
T cells that recognize their cognate pMHC and receive the proper costimulatory
signals upregulate molecules that increase their sensitivity to proliferative cytokines
(Leonard et al., 1984; Leonard et al., 1983) and that inhibit their ability to leave the
lymph node (Shiow et al., 2006). Activated T cells proliferate in the lymph node over a
three-day period, and eventually leave the lymph node through efferent lymphatics, to reenter the circulation via the thoracic duct (Gowans and Knight, 1964). Relatively little is
known about how lymphocytes exit from LNs, but it is a highly regulated process that
requires sphingosine-1-phosphate receptor-1 (S1P1) signaling (Mandala et al., 2002;
Matloubian et al., 2004).

Establishment of self-tolerance
Both T and B cell antigen receptors are assembled somatically by random
recombination of gene segments, which leads to both self- and non-self-reactivity
(Janeway et al., 2001); to avoid autoimmunity and horror autotoxicus, self-reactive cells
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must be purged. Most immunologic tolerance to self antigens is established centrally,
during T cell development in the thymus and B cell development in the bone marrow;
this prevents most autoreactive cells from ever encountering self antigens. Developing
CD4+CD8+ thymocytes are first positively selected for recognition of host antigenpresentation molecules in the thymic cortex, with cells that fail to bind MHC dying by
apoptosis, and surviving cells undergoing lineage commitment to the CD4+ or CD8+
single-positive thymocytes (Starr et al., 2003). Surviving single-positive thymocytes then
migrate to the medulla and are negatively selected for recognition of self antigens, with
cells that bind self-pMHC too tightly dying by apoptosis. The migration of singlepositive cells to the medulla is driven by their upregulation of CCR7 (Kwan and Killeen,
2004; Misslitz et al., 2004; Ueno et al., 2004); although negative selection can occur at
the double-positive stage, the thymic cortex has a very limited peptide repertoire, and DP
thymocytes do not effectively undergo negative selection. Single-positive thymocytes
remain in the medulla for 1-2 weeks while they undergo negative selection (Starr et al.,
2003); this serves to ensure that all T lymphocytes that exit to the periphery recognize
only foreign pMHC, preventing autoreactivity.
However, the mechanism of negative selection seems to be incomplete: if some
proteins (i.e. tissue-specific hormones like thyroxin or insulin) are only expressed in the
periphery and not in the thymus, autoreactive T cells can not be negatively selected
against those antigens and autoimmunity should develop. One way this problem is
avoided is by expressing many “peripheral, tissue-specific” antigens at low levels in the
medullary thymic epithelial cells that are responsible for negative selection (Anderson et
al., 2002; Liston et al., 2003; Villasenor et al., 2005). The protein AIRE (autoimmune
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regulator) is expressed in these cells and is required for the ectopic expression of mRNAs
encoding peripheral tissue-restricted antigens (Anderson et al., 2002; Liston et al., 2003);
defects in this protein cause severe autoimmune endocrinopathy in both mice (Anderson
et al., 2002; Ramsey et al., 2002) and people (known as autoimmune polyendocrinopathy
syndrome-1 [APS-1] or autoimmune polyendocrinopathy-candidiasis-ectodermal
dystrophy [APECED]; OMIM #240300) (Consortium, 1997; Nagamine et al., 1997).
The precise mechanism by which the AIRE protein contributes to central tolerance
remains somewhat controversial, with evidence suggesting that it can function both as a
transcriptional transactivator (Bjorses et al., 2000; Pitkanen et al., 2000) and as an E3
ubiquitin ligase (Uchida et al., 2004).

Maintenance of self-tolerance
It is important to note that not all tolerance is established centrally, by deletion of
autoreactive T cells from the immune repertoire. Self-reactive T cells can be found in the
peripheral blood of most healthy humans, at low but detectable frequencies (Liblau et al.,
1991; Sun et al., 1991). The forkhead box transcription factor FoxP3 is necessary for the
development of regulatory T cells with an immunosuppressive function (Tregs) (Hori et
al., 2003); inactivating mutations in FoxP3 cause fatal autoimmune disease very early in
life in both mice (Brunkow et al., 2001) and humans (Bennett et al., 2001; Chatila et al.,
2000; Wildin et al., 2001). A spontaneous frameshift mutation causes the scurfy
phenotype in mice, which is similar to the human disease immune dysregulation,
polyendocrinopathy, enteropathy, X-linked syndrome (IPEX), also called X-linked
autoimmunity–allergic disregulation syndrome (XLAAD; OMIM reference #304930).
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Further evidence that Tregs are critical in maintaining immune tolerance is
provided by their ability to suppress pathogenic responses against normal GI flora. SCID
mice that are given Treg-depleted CD4+CD45RBhighCD25- T lymphocytes develop
autoimmune gastritis and inflammatory bowel disease (Read et al., 2000; Suri-Payer and
Cantor, 2001); concurrent transfer of Tregs protects against this (Hori et al., 2003).
Recently, Rudensky’s group showed that FoxP3+ Tregs are necessary to maintain
peripheral tolerance by using knock-in mice that express a receptor for diptheria toxin
(huEGFR) specifically in FoxP3+ cells (Kim et al., 2007). Injection of diptheria toxin
causes a specific depletion of Treg cells and leads rapidly to severe lymphoproliferation.
Deletion of Tregs neonatally leads to neonatal lethality similar to that observed in scurfy
mice, while deletion of Tregs at later ages leads to rapid lymphoproliferation and
morbidity. This requirement for Tregs to suppress pathologic responses in normal,
healthy animals indicates that central tolerance alone is not sufficient to avoid
immunopathology, and that peripheral tolerance mechanisms are critically important.

Dendritic cells and self-tolerance
Over the last five-ten years, a growing body of evidence has indicated that
dendritic cells play significant roles in inducing tolerance in the absence of inflamation; it
is generally believed that the outcome of antigen presentation by DCs depends on the
state of DC maturation (Liu, 2001; Mellman and Steinman, 2001; Steinman et al., 2003a;
Steinman et al., 2003b). Immature DCs capture, process, and present a variety of self
antigens to T cells; sources of antigen include serum and environmental proteins (Holt et
al., 1988; Liu and MacPherson, 1993; Vermaelen et al., 2001), extracellular matrix
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components, and dead cells (Belz et al., 2002; Huang et al., 2000). Antigen presentation
by steady-state DCs establishes T cell tolerance to prevent adverse reactions to self when
the same antigens are presented in immunizing conditions (Brimnes et al., 2003;
Steinman et al., 2003a; Steinman et al., 2003b).
The first evidence that dendritic cells were capable of inducing antigen-specific
tolerance was obtained by injecting mice with an antibody to the dendritic cell surface
receptor 33D1; these mice were subsequently resistant to immunization with other rat
IgG2b antibodies, but generated normal responses to antibodies of other isotypes
(Finkelman et al., 1996). Simultaneous administration of inflammatory stimuli led to
heightened responses to subsequent IgG2b challenge. Subsequent, more sophisticated
experiments have suggested that the default state of antigen presentation by DCs is T cell
tolerance. Injection of mice with antigens coupled to a Dec-205-specific antibody either
by engineering them into the antibody C-terminus (Hawiger et al., 2001) or by chemical
conjugation (Bonifaz et al., 2002) led to antigen-specific T cell proliferation and
subsequent tolerance. Simultaneous administration of adjuvant and DC-targeted antigen
led to strong T cell responses to subsequent antigenic challenge (Bonifaz et al., 2002;
Bonifaz et al., 2004; Hawiger et al., 2001; Hawiger et al., 2004).
The mechanism by which steady-state tolerance is achieved seems to vary
between transgenic T cells, as tolerized HEL- and ovalbumin-specific T cells on a
C57/B6 background are deleted (Bonifaz et al., 2002; Hawiger et al., 2001), while MOGspecific T cells on the same background are not deleted but anergized, in a CD5dependent manner (Hawiger et al., 2004). Moth cytochrome c-specific AND T cells on
the B10/BR background are also anergized, not deleted (Skokos et al., 2007).
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Other groups have shown that dendritic cells can induce antigen-specific
tolerance by using mice that express foreign antigens in dendritic cells upon
administration of tamoxifen (Probst et al., 2003). Induction of LCMV epitopes under
steady-state conditions led to T cell tolerance to the induced epitopes, but not to an
uninduced LCMV epitope; challenge with LCMV resulted in rapid viral dissemination to
the spleen. In contrast, induction of LCMV epitopes concurrently with administration of
agonistic -CD40 antibody led to the development of T cell immunity strong enough to
rapidly clear virus (Probst et al., 2003). Further work from this group indicated that
steady-state DC-induced CD8+ T cell tolerance is T cell-intrinsic and requires the
costimulatory molecules PD-1 and CTLA-4 (Probst et al., 2005). T cells deficient in PD1 were not tolerized upon induction of LCMV epitopes, but wild-type congenic T cells in
the same animals were tolerized normally. Treatment of mice with a neutralizing
antibody to CTLA-4 concurrent with induction of LCMV epitopes also led to incomplete
tolerance induction.
The inducible model of Probst et al. has some imperfections – most notably, the
fact that tamoxifen and other estrogen receptor modulators used to induce antigen
expression are not entirely without effect on immune cells – but it complements the
studies that targeted DCs with modified antibodies to induce tolerance. The general
hypothesis that dendritic cells induce T cell tolerance as the default pathway, with
inflammatory stimuli required to induce priming, is well supported.
There is some evidence that stromal cells in peripheral LNs can induce tolerance,
although this remains controversial (Lee et al., 2007). LN stromal cells expressed
peripheral tissue antigens and presented them to CD8+ T cells, leading to deletional
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tolerance (Lee et al., 2007). This tends to support the hypothesis that tolerance is an
actively maintained process, not simply the absence of inflammation.
Although both DCs and Tregs contribute to and maintain peripheral tolerance, to
date, only Tregs have been shown to be necessary to avoid immunopathology. Attempts
to delete DCs and induce a loss of self-tolerance are hampered by the corresponding loss
of antigen presentation after DC deletion, which prevents the subsequent development of
autoimmunity. The more subtle experiment of inducibly inhibiting the ability of DCs to
tolerize T cells has not yet been performed, as the mechanism by which DCs induce
tolerance in T cells remains unclear, although PD-1:PD-L1 interactions seem to be
necessary (Probst et al., 2005).

Leukocyte trafficking and function
As an organ system, the immune system is unique in that cells transit extensively
between organs and the bloodstream. Lymphocytes enter lymph nodes through
specialized vascular structures known as high endothelial veins, migrate to their
appropriate location within the LN, and search the parenchyma for their antigen (Girard
and Springer, 1996; Marchesi and Gowans, 1964). Lymphocytes that fail to find their
antigen within two or three days exit the LN and enter the efferent lymph, to re-enter the
circulation through the thoracic duct (Gowans and Knight, 1964). Lymphocytes typically
spend less than 30 min in the circulation before re-entering another lymphoid organ
(Pabst, 1988). Removal of recirculating lymphocytes via thoracic duct cannulation leads
to almost complete depletion of lymphocytes, indicating that the vast majority of
lymphocytes actively recirculate (Geener and Gowans, 1962).
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Leukocyte extravasation is a multistep process, with each process involving
interactions between different leukocyte and endothelial cell proteins (von Andrian and
Mempel, 2003). Leukocytes first loosely roll along the vessel endothelium, leading to
chemokine receptor-mediated activation of integrins, which firmly adhere the leukocyte
to the vessel wall. Firmly adhered leukocytes can then diapedese across the endothelium,
pass through the basement membrane, and migrate into the tissue parenchyma. The
specific adhesion molecules and ligands differ among leukocytes and specialized
vasculature (von Andrian and Mempel, 2003); for simplicity, the entry of naïve T and B
lymphocytes into LNs through HEVs will be focused on here. The first step in leukocyte
extravasation, rolling, is mediated by L-selectins on lymphocytes, which adhere to
peripheral node addressins (PNAd), O-linked oligosaccharides related to sialyl-lewisX
(Berg et al., 1991; Streeter et al., 1988a; Streeter et al., 1988b). The L-selectin-mediated
interactions are not strong enough to fix the cell directly to the vessel wall, so shear
forces from blood flow push the leukocyte along, leading to rolling. As a lymphocyte
rolls, CCR7 is activated by HEV-bound CCL21 and CCL19, displayed on the endothelial
surface (Campbell et al., 1998a; Campbell et al., 1998b; Gunn et al., 1998); the Gilinked signaling induced by CCR7 activates the integrin leukocyte function-associated
antigen 1 (LFA-1) (Stein et al., 2000), which binds to intercellular adhesion molecule 1
(ICAM-1) on the endothelial wall (Hamann et al., 1988; Warnock et al., 1998).
Interactions between LFA-1 and ICAM-1 mediate firm adhesion, which fixes the
lymphocyte in place, allowing CD31-mediated diapedesis to occur. Once the cell has
crossed the basement membrane and entered the LN parenchyma, it can follow guidance
cues directing it to the B or T cell area, as appropriate. As an example of how homing
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receptor molecule expression controls trafficking, most myeloid cells express L-selectin,
but not CCR7, so they roll in HEVs but fail to arrest; conversely, activated effector T
cells or effector memory T cells lack L-selection and do not roll, precluding them from
homing through HEVs to LNs (Sallusto et al., 1999; von Andrian and Mempel, 2003).
Intact lymphocyte trafficking and migration is required for proper immune
function; defects in homing molecules or their ligands result in immunodeficiencies
(Etzioni and Harlan, 1999). Leukocyte adhesion deficiency type 1 (LAD 1,
MIM#116920), characterized primarily by a defect in neutrophil adhesion, is caused by
deficiencies in the beta-2 integrin CD18, which is necessary for cell-surface expression of
its dimerization partners, the alpha integrins CD11a, CD11b, and CD11c (Anderson et
al., 1984; Bowen et al., 1982; Crowley et al., 1980; Dana et al., 1984; Springer et al.,
1984). All of the L-selectin ligands require significant post-translational modifications
by glycosyl- and sulphotransferases for effective L-selection recognition; defects in the
Golgi-bound GDP-fucose transporter FucT1 lead to leukocyte adhesion deficiency type
II, or Rambam-Hasharon syndrome (MIM#266265 and #605881) (Etzioni et al., 1992;
Frydman et al., 1992; Karsan et al., 1998).
Leukocyte trafficking is not simply restricted to movement from the blood into
tissue, however; the development and life cycle of lymphocytes involve many homing
and migratory events. T cells originate as precursors in the bone marrow, enter the
bloodstream, migrate through the bloodstream into the thymus, migrate within the thymic
cortex to be positively selected and to the medulla to be negatively selected, leave the
thymus and enter the circulation as naïve T cells, enter lymph nodes through high
endothelial veins, migrate within the T cell area until it finds a dendritic cell presenting
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its cognate antigen or exit through the lymph, re-enter the circulation, and enter another
lymph node to repeat the last few steps. Upon antigen encounter, T cells are activated as
above, and ultimately exit the lymph node in the efferent lymph, to re-enter the
circulation via the thoracic duct (Gowans and Knight, 1964).
Lymphocyte homing receptors change as a function of the developmental stage;
afferent lymph contains memory, but not naïve T cells, indicating that naïve T cells can
only home to LNs through HEVs, while (some) memory T cells home from the blood to
peripheral tissues, and can travel in afferent lymph to LNs (Klonowski et al., 2004;
Mackay et al., 1990). Antigen-experienced memory T cells may be classified as effector
(TEM) or central memory (TCM) T cells, based on their expression of the cell surface
homing receptors CCR7 and CD62L (Sallusto et al., 1999). Central memory cells, like
naïve T cells, are CCR7+ and home to lymphoid tissues through HEVs in a CD62Ldependent manner. Effector memory T cells are CCR7- CD62L- and therefore cannot
home to LNs through HEVs; they home to peripheral tissues through tissue-specific
homing receptors or through receptors for inflammation-induced adhesion molecules.
Interestingly, the homing specificity of T cells is ‘imprinted’ when they are primed with
antigen (Agace, 2006; Kantele et al., 1999); one elegant study showed that intraperitoneal
injection of antigen induced both skin-homing effector cells in peripheral LNs and guthoming effector cells in gut-associated lymphoid tissues (Campbell and Butcher, 2002).
T cells home to the gut (mesenteric LNs, peyer’s patches) through receptors
including the integrin 47 and CCR9, a receptor for the intestinal epithelium chemokine
CCL25 (Hamann et al., 1994; Kantele et al., 1999; Svensson et al., 2002). These
receptors are upregulated by retinoic acid, which is produced by by gut-associated DCs
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from vitamin A (Iwata et al., 2004; Mora et al., 2003; Stagg et al., 2002). T cell homing
to skin has also been extensively studied. One skin-specific chemokine is CCL27, which
attracts the CCR10+ subset of memory T cells (Homey et al., 2002; Morales et al., 1999;
Reiss et al., 2001). The active form of vitamin D3, 1,25(OH)2D3 was found to induce
CCR10 expression on T cells and to suppress the gut-homing receptors CCR9 and 47
integrin (Sigmundsdottir et al., 2007). Interestingly, DCs were found to metabolize the
inactive prohormone vitamin D3, which is generated in the skin upon UV exposure
(Holick et al., 1980; MacLaughlin et al., 1982), to the biologically active form
(Sigmundsdottir et al., 2007). This is consistent with the emerging paradigm that DCs
activate locally generated signaling molecules to program T cell migration and trafficking
behavior.

Leukocyte migration within tissues
Migration within tissues is also critical for proper immune function – many
fundamental immune processes depend on interactions between cells, requiring that both
interacting cells find and contact each other. Naïve T cells must find their antigen on
DCs (Itano and Jenkins, 2003), Th2 cells must find their antigen on B cells (Abbas et al.,
1996; Garside et al., 1998), TFH cells must find their antigen on GC B cells (Campbell et
al., 2001; Kim et al., 2001), and B cells find their antigen on FDCs (Kosco et al., 1992;
Kosco-Vilbois, 2003) or, controversially, conventional DCs (Qi et al., 2006). For
lymphocytes to find their antigenic needle within the lymph node haystack requires
efficient search algorithms that enable cells to rapidly sample all of the incoming
antigens, as fewer than 1 in 105 cells is specific for any epitope on most pathogenic

15

molecules (Janeway et al., 2001). This occurs both through distribution of antigen
throughout the lymph node, and movement of lymphocytes within the lymph node.
Soluble antigen is rapidly distributed to dendritic cells (Itano et al., 2003) through
afferent lymphatic conduits (Sixt et al., 2005), and migrating DCs carrying larger,
particulate antigens arrive over the course of hours to days and distribute themselves
throughout the T cell area (Itano et al., 2003; Kissenpfennig et al., 2005; Lindquist et al.,
2004). The migrating dendritic cells comprise two populations: CD205int CD207lo dermal
dendritic cells, which arrive in the shallow paracortex of the LN between 6-12 hours, and
CD205hi CD207hi Langerhans cells, which arrive in the deep paracortex after at least 24
hours (Kissenpfennig et al., 2005).
Migrating DCs further distribute antigen throughout the lymph node by
transferring it to lymph node resident DCs (Allan et al., 2006; Fleeton et al., 2004; Inaba
et al., 1998); recent data has indicated that priming of T cell responses occurs through LN
resident DCs in addition to or instead of the migratory DC that brought antigen to the LN
(Allan et al., 2003; Allan et al., 2006; Belz et al., 2004; Zhao et al., 2003). HSV infection
of the epidermis leads to MHC Class I-restricted priming through antigen presentation by
LN-resident CD8+ DCs, not Langerhans cells (Allan et al., 2003; Smith et al., 2003).
Airway infection with influenza or HSV-1 leads to MHC Class I-restricted antigen
presentation by both airway-derived CD8-CD11b- DCs and CD8+ lymph-node resident
DCs (Belz et al., 2004). Vaginal infection by HSV-2 leads to MHC Class II-restricted
antigen presentation only by CD11b+ submucosal DCs, not Langerhans cells or CD8+
DCs (Zhao et al., 2003).
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Antigen transfer between DC populations does not occur in a vacuum – T cell
priming by lymph node resident DCs requires that migrating DCs find, interact with, and
properly transfer antigen to the resident DCs. The importance of cellular migration and
interactions in immune responses is therefore left as an exercise for the reader.

In vivo imaging of immune responses
Fundamentally, to determine how leukocytes behave and interact within intact,
living lymph nodes requires imaging in situ; histologic studies of fixed lymph node
sections can not reveal lymphocyte dynamics. The first studies to image intact lymph
nodes used explanted lymph nodes, perfused with warmed, oxygenated medium; images
were acquired using both standard confocal microscopy (Stoll et al., 2002) and twophoton microscopy (Miller et al., 2002). Both of these techniques provide the optical
sectioning necessary to acquire four-dimensional imaging data, but the differences in how
this is achieved leads to differences in the physiology and viability of the imaged
preparations.
Confocal fluorescence microscopy uses a pinhole to block emitted light that
originates out of the focal plane; the aperture of the pinhole determines the thickness of
the focal plane (Pawley, 2006). Multiphoton microscopy takes advantage of the ability of
fluorophores to reach their excited state by accepting either one photon with energy h,
two photons each with energy h/2, three each with h/3, and so on (Denk et al., 1990;
Xu et al., 1996; Zipfel et al., 2003). For one molecule to accept two photons within ~1016

sec requires an exceedingly high photon flux, which is only achieved at the focal point

of the laser, limiting excitation to a femtoliter volume (Zipfel et al., 2003). As
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photobleaching and phototoxicity are caused by radical side products formed from the
excited fluorophore, reducing the total volume excited in this manner dramatically
reduces the amount of phototoxicity (Widengren and Rigler, 1996). For in vivo imaging
experiments, avoiding phototoxicity is critical; early intravital experiments studying
lymphocyte motility in LNs using confocal microscopy were confounded by
phototoxicity, although this was not immediately apparent (Stoll et al., 2002). The
technical difficulty of building the pulsed lasers necessary to reach the photon flux
required for efficient two-photon excitation limited its experimental demonstration in
inorganic and organic crystals (Kaiser and Garrett, 1961, Peticolas, 1963 #599) until
thirty years after it was first theoretically predicted (Göppert-Mayer, 1931). The first use
of two-photon excitation in imaging was not until 1990, when the first two-photon laser
scanning microscope was built (Denk et al., 1990). Since then, parallel improvements in
laser and microscope technology have made multiphoton microscopy available to many
more investigators (Germain et al., 2006).
Intravital microscopy is still a relatively new technique; as of this writing, the first
papers imaging immune cells were published less than six years ago. When we began,
there were many unresolved methodological questions. How physiological are inguinal
and popliteal lymph node preparations? How accurately does an explanted LN perfused
with oxygenated medium approximate an in vivo preparation? What volume of tissue
must be imaged to yield meaningful results? On what time scale must cells be imaged –
i.e. what are appropriate intervals between subsequent images, and for how long a
duration must cells be imaged? How deep in the LN must one image to observe T cells
and DCs? Can a confocal microscope be used to image lymphoid organs, or must a
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multiphoton laser be used instead? Is the LN parenchyma isotropic – i.e. is every
direction equal, or are there tendencies to favor or avoid specific directions? After several
false starts and disagreements, a consensus has been reached for all of these questions
(Germain et al., 2006).
The first studies to image intact lymph nodes used explanted lymph nodes,
perfused with warmed, oxygenated medium; images were acquired using both standard
confocal microscopy (Stoll et al., 2002) and two-photon laser scanning microscopy
(TPLSM) (Miller et al., 2002). Stoll et al. fluorescently labeled CD4+ 5C.C7 TCR
transgenic T cells with 5- (and 6-) carboxyfluorescein diacetate succininyl ester (CFSE)
and injected them i.v. into host animals, while DiI-labeled antigen-pulsed splenic DCs
and DiD-labeled control DCs not pulsed with antigen were injected s.c. into the footpad.
Draining popliteal LNs were excised and placed in a culture dish for imaging; it was
observed that DCs preferentially formed conjugates with antigen-pulsed DCs. Repeated
time-lapse confocal imaging at a depth of up to 80 µm showed that naïve T cells were
almost stationary, and formed extremely long-lasting interactions with antigen-bearing
DCs in a 1:1 ratio. After 1.5 d of antigen-exposure, T cells separated from DCs and
moved at speeds of 5-7 µm/min (Stoll et al., 2002).
A second group maintained explanted LNs in 36 °C hyperoxygenated medium
and used multiphoton microscopy to image up to 350 mm deep in explanted inguinal LNs
(Miller et al., 2002). DCs were not directly visualized, but CD4+ T cells were labeled
with CFSE and B cells with 5- (and 6-)-(((4-chloromethyl)benzoyl)amino)tetramethylrhodamine (CMTMR). In contrast to the results obtained with confocal microscopy,
(Stoll et al., 2002), it was observed that lymphocytes were relatively motile, with T cells
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moving at average speeds of 10.8 µm/min and follicular B cells moving at 6.4 µm/min; T
cell peak velocities reached 25 µm/min (Miller et al., 2002). Overlaying the paths of both
B and T cells revealed no net directionality, and displacement from the origin was
proportional to (time)1/2, indicating that they move in a random walk; this random
movement is inconsistent with chemotaxis on a large distance scale. Antigenic challenge
led to the formation of T cell clusters and swarms, indicating that DCs are likely
interacting with more than one T cell, and that both stable and transient DC:T cell
interactions occur physiologically (Miller et al., 2002). A subsequent TPLSM study also
using explanted LNs also found that CD8+ lymphocytes move around 10 µm/min, and
that DCs can contact up to 500 different T cells per hour, showing that T cell motility lets
DCs efficiently scan the T cell repertoire (Bousso and Robey, 2003). CD8+ P14 T cells
made long-lasting interactions with gp33-pulsed DCs, with DCs simultaneously
contacting up to 10 T cells; the limiting factor for how many different T cells one DC can
engage was its surface area. (Bousso and Robey, 2003). Possible reasons for the
discrepancies between these studies include differences in tissue oxygenation, imaging
depth, and increased phototoxicity from confocal imaging; it is likely that all of these
factors contributed to reducing the speed of the lymphocytes observed by Stoll et al.
The first studies to image lymph nodes in vivo examined T cell trafficking in the
absence of antigen; CFSE-labeled DO11.10 transgenic T cells were transferred i.v. into
BALB/c mice, and inguinal LNs were surgically exposed and imaged using TPLSM
(Miller et al., 2003). Blood vessels within the LN could be visualized by injection of 200
µl of 10 mg/mL 10 kDa tetramethylrhodamine dextran, to permit the identification of T
cell zones. T cells imaged 16 – 18 h after transfer were observed to move in stop-and-go
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pattern, with peak velocities of ~25 µm/min and average velocities of ~11 µm/min;
Fourier analysis revealed a periodicity of T cell speed of roughly 1.6-2.4 min (Miller et
al., 2003). Analysis of instantaneous velocity revealed a small population moving < 3
mm/min, which corresponded not to a small population of arrested cells but to brief
pauses of many different lymphocytes (Miller et al., 2003). As observed in vitro (Miller
et al., 2002), overlaying the paths of T cells revealed no net directionality, and T cell
movement was consistent with a random walk. As chemotaxis therefore does not shape
T cell migration within the T cell zone, Miller et al. suggest that the T cell antigenic
search algorithm is a stochastic process (Miller et al., 2003).

Steady-state behavior of dendritic cells
When we began, DCs had not been imaged in vivo in the absence of
inflammation; all previous studies imaging DCs used splenic dendritic cells labeled ex
vivo with fluorescent dyes and re-injected subcutaneously. We decided that visualizing
resident dendritic cells precluded the use of ex vivo labeled DCs, and that genetic
strategies to label endogenous cells were required. The Venus variant of EYFP was
cloned into the dendritic cell-specific CD11c promoter, and BAC transgenic mice were
generated by microinjection; these mice were found to express high levels of EYFP only
in dendritic cells, with low levels of EYFP expressed in some activated B and T cells.
We adapted a method for imaging the inguinal LN previously used for video-rate
studies of lymphocyte rolling and extravasation in LN vasculature (von Andrian, 1996) to
image DCs and lymphocytes in the LN parenchyma using multiphoton laser scanning
microscopy. Our first studies were focused on resting dendritic cells, with occasional T
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or B lymphocytes transferred to provide anatomical definition; to compare endogenous
DCs with the migrant DC populations imaged by other groups, we transferred labeled
splenic DCs.

Comparison of tolerogenic and priming T cell responses
During the course of our early work, several imaging studies of immune
responses were published. Two of these studies imaged priming responses after the local
delivery of antigen in vivo (Mempel et al., 2004; Miller et al., 2004), while one study
compared in vitro tolerogenic and immunogenic responses to antigen delivered to
dendritic cells (Hugues et al., 2004). Both of the studies looking at T cell priming found
that T cells initially made short, serial contacts with DCs for the first 8 hours, before
transitioning to form stable interactions; after a second phase of stable interactions, T
cells recovered their motility and resumed making transient interactions with DCs. As
none of these studies looked at the behavior of dendritic cells in the steady state in vivo,
we decided to deliver antigen to dendritic cells using a method developed previously in
the lab (Bonifaz et al., 2002; Hawiger et al., 2001), and image the resulting DC:T cell
interactions in vivo.
It is possible to target antigens to the endocytic pathway of dendritic cells using
antibodies to cell-surface receptors such as Dec-205, (Bonifaz et al., 2002; Bonifaz et al.,
2004; Hawiger et al., 2001; Hawiger et al., 2004); peptides derived from the endocytosed
proteins are efficiently presented to T cells which, in the absence of adjuvant, are
tolerized by deletion (Hawiger et al., 2001), induction of CD4+CD25+ regulatory T cells
(Kretschmer et al., 2005; Mahnke et al., 2003), CD5 upregulation (Hawiger et al., 2004),
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or anergy induction (Skokos et al., 2007). Simultaneous CD40 ligation or stimulation
with a TLR ligand leads to dendritic cell activation and the triggering of an immunogenic
response to the peptides targeted to the dendritic cell.
Subsequent experiments were performed to image both tolerance and priming in
vivo after antigen targeting to DCs. We cloned ovalbumin epitopes into the C-terminus
of an anti-Dec-205 antibody to deliver them to dendritic cells, and injected them into
mice in the presence or absence of anti-CD40 antibody, to yield priming or tolerizing
responses, respectively. Differentially labeled fluorescent ovalbumin-specific and
nontransgenic control T cells were transferred, and intravital microscopy was performed
at various time points after T cell transfer.

TCR affinity for pMHC and T cell dynamics in vivo
Much evidence suggests that TCR affinity for MHC II:peptide complexes
(pMHC) is significant in determining T cell fate in the periphery, in addition to during
thymocyte selection (Alam et al., 1996; Madrenas and Germain, 1996; Sloan-Lancaster
and Allen, 1995). It is possible to manipulate the TCR affinity for pMHC by taking a
stimulatory pMHC and making single amino acid replacements to generate other peptides
(altered peptide ligands, or APLs) that bind the same MHC molecule (Sloan-Lancaster
and Allen, 1995). These APLs can cover a broad range of affinities and functional
outcomes, from nonstimulatory to partial agonist to superagonist (Evavold and Allen,
1991; Madrenas and Germain, 1996; Sloan-Lancaster et al., 1993). The extent of
activation induced in T cells can be used to classify these APLs, using CD69
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upregulation, proliferation, and cytokine production, in order of increasing stringency
(Daniels et al., 2006). To determine the role of pMHC potency in T cell responses, we
used the well-characterized moth cytochrome C system. Single point mutants of this
peptide have been generated, which disrupt the interaction with the AND TCR but have
no effect on binding to the I-Ek MHC II molecule (Kaye et al., 1989; Madrenas et al.,
1995; Rogers et al., 1998). As described above for the Ovalbumin peptide, we cloned the
MCC peptide and selected APLs into the C-terminus of an anti-Dec-205 antibody to
target the pepide specifically to DCs. Mice were injected with -Dec-APLs, CFPexpressing AND T cells and GFP-expressing nontransgenic T cells were transferred, and
the resulting DC-T cell interactions were visualized by intravital microscopy.

Dynamics of germinal center reactions
Humoral immunity is mediated by antibodies secreted from B cells. After being
released into the periphery, B cells can undergo secondary, antigen-dependent genetic
changes in specialized lymphoid structures called germinal centers (Jacob et al., 1991a;
Jacob et al., 1991b). Germinal center B cells (FasL+ GL-7+) proliferate rapidly, with cell
cycle durations of 6-8 hours (MacLennan, 1994); as the cells proliferate, they express
high levels of AID, which deaminates the genes coding for the B cell receptor,
introducing somatic mutations (Di Noia and Neuberger, 2002; Ramiro et al., 2003). B
cells with newly mutated antigen receptors then compete with unmutated B cells and
other newly mutated B cells for antigen, on the basis of their B cell receptor’s affinity for
the antigen. High-affinity cells outcompete lower-affinity cells, with the higher affinity
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cells continuing to proliferate, and the low-affinity cells dying by apoptosis (Kelsoe,
1996; MacLennan, 1994; Rajewsky, 1996). Germinal centers are thought to be founded
by three or four antigen-specific B cells (Kroese et al., 1987); it is believed that
centroblasts rapidly proliferate in the dark zone, and centrocytes are selected in the light
zone (Hanna, 1964; Kelsoe, 1996; MacLennan, 1994; Nossal et al., 1965; Rajewsky,
1996).
When we began, none of this had been visualized in vivo; all of the previous
studies were done histologically, on fixed sections. The only live imaging of B cell
responses was a study of early B cell activation, showing that activated B cells migrate
directionally to the T-B interface in a CCR7-dependent manner, where they form
relatively long-lasting, motile conjugates with T cells (Okada et al., 2005). B cells would
occasionally contact more than one T cell simultaneously, but T cells could only polarize
to contact one B cell at a time (Okada et al., 2005).
We thus decided to investigate the cellular dynamics of germinal center reactions
using the same microscopy techniques we had previously established. We transferred
GFP-expressing NP-specific B cells (Shih et al., 2002a; Shih et al., 2002b) and
nontransgenic CFP-expressing B cells and visualized follicular dendritic cells by s.c.
injection of a fluorescently-labeled anti-FDC-M1 antibody (Kosco et al., 1992; Szakal et
al., 1988). Inguinal LNs were imaged as above in our previous studies of DCs and T
cells, but at shallower depths, since B cell follicles and GCs are more superficial than the
T cell areas.
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SUMMARY
The goal of our experiments was to visualize in intact, living lymphoid tissue the
physiological role of dendritic cells in tolerance and immunity; this was achieved by
intravital microscopy of fluorescently-labeled DCs and lymphocytes in the inguinal
lymph nodes. We generated mice that specifically expressed EYFP in their dendritic cells
and observed both DC behavior in the steady state and migratory DC behavior in living
LNs. We investigated how tolerogenic DC:T cell interactions compared to immunogenic
interactions, and how TCR affinity for pMHC affected the dynamics of these interactions,
signaling, and functional responses. We then shifted our focus from classical dendritic
cells to follicular dendritic cells and from cellular to humoral immunity, and studied the
dynamics of GC B cells and their interactions with FDCs during germinal center
reactions.
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CHAPTER 2. METHODS

Transgenic mice. EYFP-Venus (Nagai et al., 2002) was cloned into a CD11c promoter
(Brocker et al., 1997). The linearized construct was injected into B6/CBA F1 fertilized
female pronuclei, and progeny positive by PCR for the transgene were backcrossed to
C57Bl/6 for at least 6 generations.

C57Bl/6 mice expressing ECFP on the -actin

promoter were purchased from Jackson Labs (Hadjantonakis et al., 2002). EGFP-OTII
transgenic mice were products of a cross between OTII mice and mice ubiquitously
expressing EGFP on the ubiquitin promoter (Kang et al., 2003; Wright et al., 2001);
ECFP-OTII mice are a cross between mice expressing ECFP on the -actin promoter
(Jackson Labs) and OTII mice. For the I-Ek TCR affinity experiments, AND TCR
transgenic mice expressing the V3/V11 TCR were kindly provided by Dr Lisa Denzin
and bred to B10.BR background (H2k) (Croft et al., 1992; Jaiswal et al., 1996). CD11cEYFP (Lindquist et al., 2004), ECFP (Hadjantonakis et al., 2002) and EGFP (Wright et
al., 2001) expressing mice were backcrossed to B10.BR, and ECFP-AND mice were
produced by inter-crossing. B6.SJL (CD45.1) mice were crossed with B10.BR to produce
B10.BR CD45.1 mice. For the germinal center experiments, B1-8hi BCR knock-in mice
(all B cells which express the  light chain are specific for the hapten NP) (Shih et al.,
2002a; Shih et al., 2002b) were crossed with mice expressing EGFP or CD45.1. Mice
were used for experiments at 5-10 weeks of age; all mice were housed in specific
pathogen-free conditions and were treated in accordance with the Institutional Animal
Care and Use Committee protocols of Rockefeller University and New York University
Medical Center (New York, New York)
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Immunofluorescence. Lymph nodes were fixed in PBS with 4% paraformaldehyde +
10% sucrose and cryoprotected in PBS + 30% sucrose before embedding in OCT and
freezing. Frozen tissue was sectioned (20 or 50 m) on a microtome and fixed in
acetone; all subsequent incubations were performed in a humidified chamber. Sections
were blocked in 5% BSA, 10% serum in PBS in the presence of -CD16/CD32 (BD
Biosciences), and sequentially blocked with excess streptavidin and biotin (Vector Labs).
For peroxidase amplification with biotinyl tyramides (NEN), we quenched endogenous
peroxidase activity with 3% H2O2 in PBS before the initial blocking step as per the NEN
protocol. Slides were incubated with the appropriate antibodies for 30 to 90 minutes,
depending on the individual antibody’s affinity; slides were washed 3 times in PBS
between antibody stainings. When applicable, slides were incubated with fluorochromeconjugated streptavidin for 30 minutes, after which slides were washed three times in
PBS and dipped briefly in ddH2O immediately before mounting. The antibodies used
were: directly labeled -CD3-Alexa 647, -B220-Alexa 647 (CalTag), -B220-Pacific
Blue (BD Biosciences), biotinylated -CD3, -CD1b, -CD11c, -CD19, -CD80, CD86, -B220, -F4/80, -Gr-1, -I-Ab, -PECAM, -rat IgM (BD Biosciences),
MOMA-1 (BMA Biomedicals), -CD11c, -CD45.2 (EBioscience), unconjugated
MECA-79 (BD Biosciences) and biotin and Alexa 647 conjugates of -DEC-205
produced and conjugated by the RU Monoclonal Antibody Core Facility. Anti-FDC-M1
was purified from hybridomas (Kosco et al., 1992; Kosco et al., 1988; Szakal et al., 1988)
and labelled in-house with Alexa 546, 594, and 647. Streptavidin-Cy3 and -Cy5 were
from Jackson ImmunoResearch; TO-PRO-3 was from Molecular Probes. Sections were
mounted in Fluoromount-G (Southern Biotech) and stored at 4 °C.
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Confocal microscopy. Confocal images were acquired on a Zeiss LSM 510 system with
405, 488, 543, and 633 nm excitation lines; EYFP, EGFP and ECFP fluorescence were
visualized directly in all images. Images with ECFP and EYFP fluorescence were
captured using 458 and 514 nm excitation lines. An array of 40x or 63x images was
taken with a motorized stage to capture the entire cut surface of the lymph node, and
images were exported into Adobe Photoshop for final processing. Three-dimensional
reconstructions were generated from Z-stacks using Imaris (Bitplane). Positions of T
cells, HEVs, and the deep paracortex were measured in Volocity software. Cells were
scored as being in the deep paracortex only if the entire cell was within the boundary;
cells touching the boundary were excluded. The minimum distance from T cells to HEVs
were calculated as in Bajenoff et al.(Bajenoff et al., 2003) with the following equation: Di
= min [(Xi-Xj)2 + (yi-yj)2], where i and j are indices from 1…n for T cells and HEVs,
respectively, and min is the minimum function. It should be noted that this yields the
distance to the center of the HEV, which is greater than the distance to the basal side of
the HEV endothelium. To further refine this measurement, images and T cell positions
were imported into MatLab, and the distance from each T cell to the wall of the nearest
HEV was measured by a custom script based upon the same formula.

Flow cytometry analysis of DCs. Single cell suspensions from lymph nodes were pretreated with -CD16/CD32 and stained with CD11c-APC and biotinylated antibodies
specific for: CD3, CD4, CD8a, CD11b, CD19, B220, CD86, DEC-205 and MHC class II
(I-Ab) (BD Biosciences). Living cells were gated based on forward and side-scatter on a
FACSVantage SE (Becton-Dickinson) and data analyzed using FlowJo (TreeStar).
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Recombinant antibody production. Anti-DEC-OVA, and Iso-OVA were constructed
by cloning the C-terminal portion of Ovalbumin protein into the C-terminus of the DEC-205 antibody NLDC-145 or isotype control (III-10) (Hawiger et al., 2001; Hawiger
et al., 2004); the control antibody -DEC-CSP (anti-DEC-205 fused to the irrelevant
peptide SYVPSAEQI) was produced by similarly cloning the sequence encoding
SYVPSAEQI into the C-terminus of NLDC-145. Anti-DEC-MCC, isotype-MCC and all
-DEC-APL variants were similarly constructed by cloning the C-terminal portion of
MCC (residues 81-103) and its variants into the C-terminus of the -DEC-205 antibody
NLDC-145 or isotype control (III-10). The Quickchange II Kit (Stratagene) was used to
introduce single point mutations and produce the MCC variants. Recombinant antibodies
were produced by transient transfection and were purified as described (Hawiger et al.,
2001).

Cell transfer, labeling, and antigen delivery for imaging experiments. To demarcate
B cell follicles, we transferred 1 x 108 B cells purified from EGFP+ C57BL/6 mice by
magnetic depletion with -CD43 microbeads (Miltenyi Biotec). To image transferred
dendritic cells, CD11c+ DCs were purified by immunomagnetic selection from the
spleens of ECFP+ mice injected with cells from a Flt3L-expressing tumor and 4-6 x 106
cells intradermally injected with 1 ng/µl LPS (Sigma) at 4 sites surrounding the inguinal
lymph node. To image the macrophages in the subcapsular sinus and blood vessels
throughout the lymph node, we injected 1 mg of rhodamine-dextran (66 kDa) (Molecular
Probes) in 100 l saline subcutaneously in the base of the tail. To examine high
endothelial veins in vivo, we injected 10 µg of Alexa 594-labeled MECA-79 antibody
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intravenously in the retro-orbital sinus. To label follicular dendritic cells (FDCs) in vivo,
we injected 25 µg of FDC-M1 antibody (purified as above) labeled with Alexa 546, 594,
or 647.
To deliver Ovalbumin epitopes to DCs, we injected CD11c-EYFP mice with 2 g
i.p. of -DEC-OVA, Iso-OVA or -DEC-CLS either alone or together with -CD40
(clone 1C10, 50 g). Five hours later mice were injected i.v. with 1-2 x 107 purified
EGFP-OTII cells and naïve CD4+ ECFP-T cells (>98% purity) prepared by magnetic
depletion of non-CD4+ T cells (MACS CD4+ T cell Kit, Miltenyi Biotec). LNs were
imaged 2-18 hours after T cell transfer, as described below.
To deliver MCC epitopes to DCs, CD11c-EYFP mice were injected i.p. with 10
µg of -DEC-MCC or the indicated -DEC-APL variant; 5 h later, we adoptively
transferred 1 x 107 ECFP-AND CD4+ T cells and an equal number of non-transgenic
EGFP+ CD4+ T cells. All T cells were purified by negative selection with a CD4+ T cell
isolation kit (Miltenyi). LNs were imaged from 1-6 hours after T cell transfer, as
described below.
To image germinal centers, we first primed WT B6 mice with i.p. injections of
100 ug of Ova/alum. Between 14-28 days later, NP-specific splenic B cells were isolated
from the spleens of B1-8hi mice by negative selection with anti-CD43, anti-CD11c, antiCD90 and anti- light chain Abs. For most experiments, 2.5 x 106 B1-8hi cells were
transferred into the primed mice, with between 10 and 30% of the B1-8hi cells expressing
EGFP. One day after B cell transfer, mice were injected s.c. in the footpad and thigh with
200 ug of NP-Ova. Five days post-boost, polyclonal B cells were purified from spleens of
B6/SJL (CD45.1) CFP-expressing mice by negative selection with anti-CD43, anti-
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CD11c and anti-CD90; 2 x 107 polyclonal B cells were transferred i.v., and labeled FDCM1 antibody was injected.

In vivo OT-II T cell responses. OT-II T cells (CD45.2) were labeled with
carboxyfluorescein diacetate succinimidyl ester (CFSE), transferred into 4-6 week-old
B6/SJL (CD45.1) mice and challenged i.p. 24 h later with 2 g of -DEC-OVA, 2 g
Iso-OVA, PBS, or 2 g -DEC-OVA plus 90 g CD40. T cells were purified from
peripheral LNs 3 d or 7 d later and either cultured with irradiated CD11c+ cells and OVA
peptide to measure proliferation or analyzed by flow cytometry on a FACSCalibur (BD
Pharmingen) to measure CFSE dye dilution (gated on V2 and CD45.2). To monitor
early T cell activation, CD45.2 OT-II T cells were transferred into CD45.1 B6/SJL mice
injected with -DEC-OVA (with or without -CD40) five hours previously; T cells were
purified from LNs at 3, 12, or 24 h after T cell transfer and analyzed by flow cytometry to
measure surface expression of CD69 and CD62L (gated on V2 and CD45.2).
Antibodies were from BD Pharmingen.

In vivo B cell experiments - Germinal Center joining and affinity. To study the
ability of B cells to join GC reactions, we first primed WT B6 mice with i.p. injections of
100 µg of Ova/alum. Two weeks later, mice were injected s.c. in the footpad and thigh
with 200 µg of NP-Ova. NP-specific B cells were isolated from the spleens of B1-8hi
mice by negative selection with anti-CD43, anti-CD11c, anti-CD90 and anti- light chain
Abs. B cells were transferred concurrently with the boost, or 6 or 9 days later;
approximately 2.5 x 106 B1-8hi cells were transferred into the primed mice. Six days
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after B cell transfer, lymph nodes were harvested and processed for histological analysis
as above.
To examine the effect of B cell affinity on GC joining, we first primed WT, B18lo, or B1-8hi mice with i.p. injections of 100 µg of Ova/alum. Two weeks later, mice
were injected s.c. in the footpad and thigh with 200 µg of NP-Ova. Six days after the
boost, NP-specific B1-8lo cells were purified as above and transferred; six days after
transfer, lymph nodes were harvested and processed for histological analysis as above.

In vivo AND T cell responses. AND T cells (CD45.2) were labeled with CFSE,
transferred into 6-8 week old B10.BR CD45.1 mice, and challenged subcutaneously 24 h
later with 10 µg -DEC-MCC, -DEC-L98A, -DEC-Y97K, -DEC-T102L, Iso-MCC,
or PBS. T cells were purified from peripheral lymph nodes 3 d or 7 d later and cultured
with irradiated CD11c+ cells and MCC peptide to measure proliferation, or were analyzed
by flow cytometry on a FACSCalibur (BD Pharmingen) to measure CFSE dye dilution
(gated on CD4, V11/V3, and CD45.2). To monitor early T cell activation, CD45.2+
AND CD4+ T cells were transferred into CD45.1+ B10.BR mice injected 5 h previously
with -DEC-MCC, -DEC-APLs, or Iso-MCC. T cells were purified from lymph nodes
at 3 and 72 h after T cell transfer and were analyzed by flow cytometry to measure
surface expression of CD62L and CD25 (gated on CD4, V11/V3, and CD45.2).
Antibodies were from BD Pharmingen.

Surgery for intravital imaging of inguinal LN. To image mice on the B6 background,
mice were anaesthetized with 100 mg ketamine, 15 mg xylazine and 2.5 mg
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acepromazine per kg, and kept anaesthetized with hourly injections of half this dose.
Mice were restrained on a stage warmer at 37 ºC (BioTherm Micro S37, Biogenics) and
the abdominal skin was incised from the edge of the rib cage through the midline to the
thigh. A skin flap was separated from the abdominal muscle to expose the inguinal lymph
node.
To image mice on the B10/BR background (in the AND experiments), mice were
anaesthetized with 450 mg/kg avertin (Tribromoethanol, Pfaltz & Bauer, Waterbury, CT),
and kept anaesthetized with injections of a third of this dose every 30 min. Mice were
restrained and kept normothermic as described below, and their inguinal lymph nodes
were microsurgically exposed for 2-photon intravital imaging as below.
To stabilize, moisturize and maintain the lymph node at 37 ºC, we placed the skin
flap on a thermoconductive base made of silicone elastomer (Sylgard 184, Dow Corning)
surrounding a core of thermoconductive putty (T-putty 502, Thermagon). The connective
and adipose tissue covering the lymph node was removed microsurgically, keeping blood
and lymph vessels intact, and a saline-filled chamber consisting of a cover-slip glued to a
nylon washer was mounted on the skin flap over the lymph node. The chamber was
laterally secured by 3 insect pins piercing the skin and lodged in the silicone base. The
temperature was monitored using a probe (Bioptechs) placed near the lymph node to
ensure that it was at 37±1 ºC. To compensate for anesthesia-induced respiratory
depression, we provided mice with 100% oxygen by mask throughout the imaging
session.

Intravital microscopy. The lymph node was imaged using a Bio-Rad Radiance
multiphoton microscope fitted with a Tsunami pulsed laser (Spectraphysics) and a Nikon
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40x objective (water-immersed, NA 0.8), controlled by Lasersharp2000 software (BioRad). To image EYFP, EGFP and ECFP, the excitation wavelength was set to 910 nm;
experiments using rhodamine dextrans or Alexa 633/546-labeled anti-FDC-M1 antibody
were imaged at 870 nm. Band-pass filters optimized for detecting EYFP (550/30) and
ECFP (510/30) and a 530 long-pass dichroic mirror were used to detect fluorescent
proteins, with EGFP bright in both channels. Blood flow was visualized with 655 nmemitting quantum dots (Invitrogen/Quantum Dot Corp., Hayward, Ca), excited at 910 nm.
To create time-lapse sequences, we typically scanned 50x300x300 m volumes of tissue
at 6 µm Z-steps and 35 second intervals.

Data analysis. Cell movement was analyzed with Volocity software (Improvision). The
position of each cell was tracked in three dimensions over time, and displacement and
motility parameters were calculated for each cell. These include measurements of cell
velocity, cell directionality, and cell-cell contact duration, information that can only be
acquired by directly visualizing the interacting cells. Both instantaneous measurements
and per-cell average measurements of velocity and immobility are taken; the percent of
each track during which cells are immobile is termed the arrest coefficient (Hugues et al.,
2004). The motility coefficient is the slope of the linear portion of the curve obtained
when mean displacement is plotted against the square root of time, and is analogous to
the diffusion coefficient of a particle exhibiting Brownian motion (Mempel et al., 2004;
Sumen et al., 2004). Measurements of directionality include the confinement index and
turning angle. The confinement index is the ratio of the maximum displacement to the
total path length, and reflects the directionality of cell movement over the entire path
(Hugues et al., 2004). The turning angle between velocity vectors at subsequent
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timepoints provides an instantaneous measure of directionality (Mempel et al., 2004). As
a general rule, arrested cells move less directionally than freely moving cells. Cell
confinement and pausing are also analyzed. Cells which move freely in a random-walk
pattern exhibit a linear relationship between their displacement and the square root of
time, while cells which are confined within a smaller volume plateau at a given
displacement. To examine cell-cell interactions, the duration of cell-cell contacts can be
measured manually; the time a cell spends paused can be analyzed as a function of
distance to another cell, to determine if relationships exist.
When tracking dendritic cells (Lindquist et al., 2004), to eliminate motion
artifacts caused by dendrite probing, pulse and breathing, displacements smaller than 2.5
µm were filtered out of the cell tracks by a smoothing algorithm. Despite efforts to filter
high frequency movement related to probing, DC that were clearly sessile still appear to
have velocities up to 2 µm/min; this velocity was therefore used as the threshold below
which cells were considered sessile. Since cell speed exhibited an asymmetrical
distribution, data was presented in scattergrams and compared using a non-parametric
bootstrapping procedure based on 10,000 resampling iterations (Efron and . 1979). P
values smaller than 0.05 were considered significant.
When tracking T and B cells (Schwickert et al., 2007; Shakhar et al., 2005), they
were characterized as immobile if their average velocity was less than 2 µm/min. The
arrest coefficient was calculated as the percentage of each track in which the cell moved
more slowly than 2 µm/min (Hugues et al., 2004). Measurements of directionality such
as turning angle and confinement index were also calculated as above. Multivariate
ANOVA was conducted to assess statistical significance, and planned contrasts were
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used to assess differences between individual conditions. P values smaller than 0.05
were considered significant.
In the AND experiments (Skokos et al., 2007), the analysis was as described
above (Shakhar et al., 2005), while additionally taking full advantage of our
nontransgenic internal control T cells. To control for variability between different
imaging fields and mice regardless of the experimental conditions, the average speed of
control (non-TCR-transgenic) T cells in each field was calculated and used as a reference
for the speed of TCR-transgenic T cells. The mean velocity for each cell in a given field
was calculated and plotted as a percentage of the mean velocity of all the nontransgenic
cells in that field; this allowed us to make more accurate quantitative comparisons
between imaging fields. To illustrate confinement, cell tracks were superimposed on one
starting point; the resulting sphere illustrates the mean cell displacement.
In the germinal center experiments (Schwickert et al., 2007), the general analysis
of lymphocyte speed and confinement was as above. We additionally calculated plots of
displacement v. (time)1/2 to measure the extent to which individual cells were confined
within any particular volume. We further measured the duration of B cell-FDC contacts,
by counting the number of frames (2) in which cells remained in contact. Scattergrams
of individual contact time were prepared, and statistical significance was assessed by
either Student’s T-test or analysis of variance (ANOVA) with Bonferroni post hoc
corrections.

Altered peptide ligand (APL) synthesis. Wild-type and single substitution variants of
the 23 amino-acid immunogenic MCC peptide VFAGLKKANERADLIAYLKQTAK
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(81-103) were synthesized by the Proteomics Resource Center, Rockefeller University.
The APL synthesized were: L98A (substitution of leucine with alanine at position 98),
Y97K (substitution of tyrosine with lysine at position 97) and T102L (substitution of
threonine with leucine at position 102).
In vitro T cell responses. CD4+ T cells were purified from the spleen and lymph nodes
of AND mice by negative selection with a CD4+ T cell isolation kit (Miltenyi). DCs were
isolated from the spleen of B10.BR mice by positive selection with a CD11c+ isolation
kit (Miltenyi). CD4+ T cells and irradiated DCs were plated in 96-well flat-bottom plates
with different doses of WT and mutant peptides. The cultures were incubated for 60 to 72
h as indicated in the figure legends and then were pulsed with (3H) thymidine at 1
µCi/well for the final 8 h before harvesting with a 96-well channel harvester.

IFN- production was measured by ELISPOT. ELISPOT plates (MAHAS,
Millipore) were coated with 10 µg of the anti-mouse IFN- mAb (clone R4-6A2, BD
Pharmingen) overnight at 4°C and plates were blocked by incubation with PBS BSA 1%
for at least 2 h at 37°C. Lymph node CD4+ T cells were purified by negative selection
with a CD4+ T cell isolation kit (Miltenyi Biotech). Purified T cells were then cultured at
106/ml for 36-40 hours at 37 °C with 5% CO2 in the presence of 2 µM peptide and
CD11c+ DCs purified by positive selection. Plates were developed with IFN-
biotinylated antibody (BD Pharmingen) and spots visualized with avidin-HRP (Vector)
followed by DAB as substrate (Invitrogen). Spots were counted in an ELISPOT reader
(Autoimmun Diagnostika GmbH, Germany).

38

In vitro calcium measurements. Intracellular calcium concentrations were measured
using the calcium sensitive ratiometric dye Fura-2. Activated AND T cells (see below)
were labeled with 2 µM of Fura-2 in serum free media for 30 minutes at room
temperature, washed and incubated at 37°C for 30 minutes in serum containing media
before being used. Cells were then incubated on glass supported planar bilayers
containing 2 molecules/µm2 of relevant peptide loaded I-Ek and 300 molecules/µm2 of
GPI-anchored ICAM-1. Images were acquired through a 40 x NA 1.3 NeoFluar objective
at intervals of 30 seconds for a period of 20 minutes. The ratio of emission at 510 nm
excited at 340 nm and 380 nm was determined with appropriate background subtraction,
and cells forming contacts with the bilayer were tracked using Volocity software
(Improvision). High Ca2+ and low Ca2+ values were determined at the end of each
experiment by infusing media containing respectively: 1 µM ionomycin + 1 mM Ca2+ + 2
mM Mg2+, and 3 mM Mg2++ 2 mM EGTA + 0 mM Ca2+.
The Ca++ response of naïve AND TCR T cells to peptides presented on freshly
isolated CD11c+ DCs was measured in vitro. Naïve AND T cells and CD11c+ DCs were
purified from lymph nodes as described. Naïve AND T cells were labeled with 5 µM
Fura-2 in media containing 1% FBS and 0.1 mg/ml Pluronic F127 for 25 minutes at room
temperature. CD11c+ DCs were incubated with various concentrations of L98A or T102L
at 37 °C for 2 hours at a density of 106 DCs /well (Nunc 8 well glass bottom chambers,
Fisher). 0.5 x 106 Fura-2 labeled naïve AND T cells were added into the well and imaged
for 20 minutes and the Fura-2 ratio was determined for conjugates of T cells and DCs. A
threshold Fura-2 ratio of 0.4 was used to score T cells conjugated with DCs with high
cytoplasmic calcium concentrations. This threshold was determined by imaging T cells
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on bilayers containing ICAM-1 under similar imaging conditions. An average ratio of 0.3
was obtained for cells on ICAM-1. Cells interacting with bilayers containing agonist
peptides loaded on MHC had a range of Fura-2 ratios from 0.4 to 0.9 and hence a
threshold of 0.4 was used to score high calcium values. In each condition the percentage
of T cells conjugated with DCs having a Fura-2 ratio greater than 0.4 was determined.
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CHAPTER 3. IMAGING DCS IN VIVO

CD11c-EYFP mice express EYFP specifically in their dendritic cells
To create mice with fluorescently-labeled dendritic cells, transgenic mice that
express the Venus variant of EYFP (F46L/F64L/M153T/V163A/S175G) (Nagai et al.,
2002) under the control of the CD11c promoter were made by pronuclear injection, and
progeny positive for the transgene were backcrossed to C57/Bl6 mice (Lindquist et al.,
2004). We examined intact explanted lymph nodes from two transgenic lines by twophoton microscopy to determine their suitability for deep-tissue imaging. These mice
express high levels of EYFP specifically in CD11chi dendritic cells, which are visible in
lymph nodes up to 300 m deep (Figure 3.1; Movies 3.1,3.2). To define the B cell
follicle and give anatomical context within the LN, we transferred 108 naïve GFPexpressing B cells purified by negative immunomagnetic selection with CD43 beads.
Like wild-type CD11chi DCs, EYFP DCs in our transgenic mouse express heterogenous
levels of maturation markers, both by FACS (Figure 3.2) and by immunofluorescence
(Figure 3.3). It should be noted that some B cells and activated T cells also express
CD11c, and have EYFP expression at least one log lower than the CD11chi DCs (Figure
3.2). Plasmacytoid DCs (CD11cint, B220+ CD19- Gr1+ do not express significant levels
of EYFP (Figure 3.2). The CD11chi EYFPhi dendritic cells that are bright enough to be
visible in the microscope are primarily located in the T-cell area of the lymph node, and
are not related anatomically to the vasculature in most LNs (Figure 3.3).
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Blood and lymph flow are preserved during intravital imaging
To verify that the microsurgical preparation of the inguinal lymph node did not
disrupt blood flow, we injected mice with 66 kDa rhodamine dextran i.v. Blood flow was
clearly visible in imaged fields, and it was possible to distinguish HEVs by their width
and the shadows of lymphocytes adhering to their walls (Movie 3.3). To verify that
lymphatic drainage was intact, we injected mice with 66 kDa rhodamine dextran s.c. and
imaged the efferent lymphatic vessels from the inguinal lymph node. Pulsatile flow in
the lymphatic vessels was observed (Movie 3.4), indicating that efferent drainage is
intact. Occasionally, T cell extravasation was observed (Movie 3.5), providing further
evidence that the physiology of our imaged lymph nodes is grossly intact. Phototoxicity
was occasionally observed (Movie 3.6); we found that DC dendrite probing correlated
well with lymphocyte motility. We therefore used the behavior of DCs as an indicator of
local viability when determining which imaging sequences were suitable for analysis.

Dendritic cell movement varies by microanatomical location
We used intravital microscopy to examine the inguinal LN of anesthetized mice,
and saw two distinct types of cell motility: crawling - translational movement, and
probing – extension and retraction of cell processes. The most superficial DCs were
found in the subcapsular sinus and crawled slowly around relatively sessile macrophages,
while rapidly probing with their processes. (Figure 3.4a; Movies 3.7, 3.8). Other DCs
in the subcapsular sinus exhibited rapid, directed translational movement into the
parenchyma of the lymph node and may be recent immigrants from the afferent lymph
(Movie 3.7).
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Most of the DCs in the LN parenchyma were found in extensive networks in and
around the T cell area. DCs in deep paracortical networks showed significant probing
movements but were largely sessile (Figure 3.4b; Movies 3.9, 3.10). Another population
of perifollicular DCs between the B cell follicle and subcapsular sinus showed mostly
probing motions and appeared well-positioned to acquire antigens from incoming lymph
(Figure 3.4c; Movies 3.11, 3.12). DCs were relatively sparse in B cell follicles, and
individual DCs showed a crawling movement, often directionally (Figure 3.4e; Movie
3.12).

Dendritic cells form clusters with B and T lymphocytes at the B-T interface
At the interface between the B and T cell areas we often found DCs in stable
clusters that varied in size and contained round, lymphocyte-sized inclusions that lacked
EYFP (Figure 3.4d; Movies 3.13, 3.14). DCs in clusters moved dynamically, and
frequently appeared to capture freely-moving cells (Movie 3.15). To determine the
cellular composition of these clusters, we performed immunohistology on thick LN
sections and examined 3D reconstructions of confocal micrographs. Clusters were found
to contain B and T lymphocytes (Figure 3.5). Because of the tight packing of DCs, it is
impossible to count the DCs in a cluster by the EYFP signal alone, so we stained thick
sections with TO-PRO-3 to visualize nuclei and examined reconstructions as above
(Figure 3.6); clusters typically contained up to 8 DCs.
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Migrant DCs join the endogenous DC network
All of the previous intravital imaging experiments on DCs used purified splenic
dendritic cells, which were matured by exposure to adjuvant and injected back into mice,
where they migrated to the LN. The relationship of these migrant DC to the endogenous
DC residing in the LN in the steady state, however, was unclear.
Following the protocol used by Mempel et al. (2004), we purified splenic DCs
from ECFP-expressing mice and injected them intradermally with LPS to induce
maturation and CCR7 upregulation. We then followed the course of DC migration to
LNs and saw that the migrant ECFP DCs distributed throughout the T-cell area of the LN
(Figure 3.7). Over the course of ~24 h, they migrated to the LN and incorporated into
the network of EYFP DCs, gradually slowing down over time. The injection of LPS
caused the recruitment of dermal EYFP DCs to the LN, leading to an increase in the
mean cell velocity of EYFP DCs to twice their steady-state velocity by 72 h postinjection (Figure 3.7; Movie 3.16). At all timepoints, however, the migrant ECFP DCs
moved more rapidly than the endogenous EYFP DCs. Anecdotally, we rarely observed
DCs entering the circulation through HEVs (Movie 3.17); we did not observe this
frequently enough to judge its dependence on inflammatory or other stimuli.
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Figure 3.1 Brightness and surface markers of CD11c-EYFP cells. (a) Two-photon
fluorescence images descending along the z-axis through explanted lymph nodes from
CD11c-EYFPhi and CD11c-EYFPlo mice, with EYFP in green and second harmonics
from collagen fibers in blue; depth from the apex of the lymph node is indicated in
microns. Only CD11c-EYFPhi cells can be visualized deep within the lymph node. (b)
Fluorescence micrograph of lymph node sections from WT, CD11c-EYFPlo, and CD11cEYFPhi mice stained with -CD3 (red) and -B220 (blue); EYFP fluorescence was
visualized directly as described in Methods. Scale bars are 200 µm. (c) Confocal
micrograph of lymph node sections immunostained for CD11c in red, with EYFP
fluorescence in green. Scale bars are 10 µm.
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Figure 3.2 Flow cytometric analysis of EYFP cells visible by two-photon microscopy.
(a) To determine the phenotype of visible EYFP cells, we compared EYFP fluorescence
of lymph node cells from EYFPhi mice and EYFPlo mice. Since the brightest cells in
EYFPlo mice are barely visible by two photon microscopy, we used their brightness as the
threshold for gating lymph node cells from EYFPhi mice. (b) Surface marker expression
of cells from EYFPhi mice. Only population I is visible with two-photon microscopy, and
consists almost exclusively of DCs. Population II contains mainly B cells, and population
III consists largely of plasmacytoid DCs.
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Figure 3.3 CD11c-EYFP mice examined by immunofluorescence. (a-i) Confocal
micrographs of lymph node sections stained for the indicated cell surface markers in red
and counterstained in blue with CD3 or B220 to provide anatomical definition within the
lymph node. Squares linked to arrows indicate the area that was magnified. The scale bar
represents 200 µm in low resolution panels and 100 µm in high magnification insets. The
results are representative of at least three experiments.
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Figure 3.4 Anatomic distribution and behavior of DCs within the lymph node.
Inguinal lymph nodes from CD11c-EYFP mice were examined by intravital microscopy;
each panel is associated with the indicated supplementary videos. EYFP fluorescence is
in green; scale bars are 50 µm. (a) Subcapsular DCs surrounded by macrophages which
have taken up Rhodamine-labeled dextran. (b) DCs in the T cell area of the lymph nodes,
with transferred EGFP T cells false-colored red. (c) DCs form a network surrounding the
B-cell follicles. (d) DC cluster at the boundary between T and B-cell areas. (e) Schematic
diagram of the inguinal lymph node indicating the anatomic locations of the DCs shown
in other panels. (f) DCs in a B cell follicle, with transferred EGFP B cells false-colored
blue. (g) Crawling speed of DCs varies with anatomic location. Each point represents the
average speed of one cell as calculated by the movement of the centroid; velocities less
than 2 µm/min are considered sessile. Median speeds are indicated by horizontal bars.
Cells tend to arrest when incorporated into cell networks, although individual fast moving
cells do occur in all locations. The results summarize at least 3 imaging sessions in each
location.
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Figure 3.5 CD11c+ DCs form clusters with T and B cells in the steady state.
(a) Series of confocal images optically sectioning an inguinal lymph node, with EYFP in
green, CD3 in red and B220 in blue (see also Supplementary Video 12 on-line). Scale
bars are 10 mm. (b) Low-power view fluorescence micrograph of entire lymph node
section shown above, with the cluster denoted in the inset. Scale bar is 200 mm.
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Figure 3.6 DC clusters include more than one DC. Series of confocal images optically
sectioning an inguinal lymph node, with EYFP in green, DNA in red (TO-PRO 3), and
CD3 and CD19 in blue. Nuclei from DCs in a single cluster are indicated with arrows.
Note that DCs (A–H) exhibit no CD3 or CD19 staining.
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Figure 3.7 Transferred ECFP DCs gradually incorporate into the endogenous DC
network. Splenic DCs were purified by immunomagnetic selection from the spleens of
ECFP mice injected s.c. with a Flt3L-secreting tumor, and 4-6 x 106 cells were
intradermally injected with LPS into the flank of CD11c-EYFP mice. Inguinal LNs were
examined by immunofluorescence and intravital microscopy at the indicated time points.
(a) Confocal micrograph of inguinal LNs immunostained for HEVs with MECA-79
antibody. Scale bar is 200 µm in low resolution panels and 100 µm in high magnification
insets; optical thickness is 10 µm in the ECFP channel and 1.2 µm in all other channels.
(b) Plots of displacement versus (time)1/2, used to calculate the motility coefficient of
transferred (filled circles) and endogenous (open circles) cells. Inguinal LNs were imaged
by multiphoton microscopy, and cells were tracked as above; the motility of transferred
DCs gradually decreases as the cells incorporate into the endogenous DC network. (c)
Scattergram of the average velocities of individual transferred and endogenous DCs at the
indicated time points. Panels (b) and (c) summarize at least 4 imaging fields examined in
each time point.
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CHAPTER 4. DC:T CELL INTERACTIONS UNDER TOLERIZING AND
IMMUNIZING CONDITIONS

Several groups have visualized DC:T cell interactions using purified, in vitro
labeled, adjuvant-matured splenic dendritic cells and transgenic T cells (Bousso and
Robey, 2003; Mempel et al., 2004; Miller et al., 2004a; Miller et al., 2004b; Miller et al.,
2003; Stoll et al., 2002), but these methodologies limit the applicability of the results to
DCs that mature in the periphery, precluding direct comparison with steady-state DC:T
cell interactions. We took advantage of a method previously used in the lab to deliver
antigen specifically to DCs (Bonifaz et al., 2002; Hawiger et al., 2001). Simultaneous
CD40 ligation or stimulation with a TLR ligand leads to dendritic cell activation and the
triggering of an immunogenic response to the peptides targeted to the dendritic cell
(Bonifaz et al., 2002; Hawiger et al., 2001).
Specific antigens are targeted to dendritic cells by using a previously described
recombinant anti-Dec-205 antibody with a C-terminal region containing an antigenic
peptide as well as sequences that direct proper proteolytic processing and presentation
(Hawiger et al., 2001); we cloned Ovalbumin peptide into the C-terminal region of this
antibody, injected it into mice, and examined T cell activation after dendritic cell
targeting. Naïve OT-II T cells were transferred i.v. into WT mice, and injected with
antigen 24 h later. Antigen delivery by -Dec-Ova activates tolerized and primed OTII T
cells to a similar extent, as measured by upregulation of early activation markers,
proliferation, and response to antigen at three days (Figure 4.1). By seven days after
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antigen delivery, OT-II T cells are deleted in the absence of a priming stimulus; the few
cells that remain do not proliferate in response to peptide rechallenge (Figure 4.1).

Tolerance and priming are characterized by similar retention near HEVs
We analyzed the distribution of specific and non-specific T cells throughout the
LN, by transferring GFP-expressing OT-II or non-TCR-transgenic cells into WT mice,
delivering -Dec-Ova, and examining frozen LN sections histologically. We quantified
the distribution by dividing the LN into superficial and deep regions, and counting the
number of T cells in each region, as well as by measuring the position of all T cells and
HEVs and calculating the distance from each T cell to the nearest HEV. Both primed and
tolerized cells were retained specifically near HEVs at 3 h after transfer, while nonspecific T cells were present throughout the T cell area (Figure 4.2). By 24 h after
transfer, both tolerized and primed cells had distributed evenly throughout the LN.

Imaging tolerance and immunity
To image the induction of T cell tolerance, fluorescently-labeled T cells are
transferred into CD11c-EYFP+ mice and the cellular interactions in the inguinal lymph
node are visualized by intravital microscopy (Figure 4.3). As described above, to target
antigen specifically to DCs, we injected mice with -Dec-Ova (Hawiger et al., 2001).
Fluorescently-labeled T cells are purified from mice ubiquitously expressing ECFP
(Hadjantonakis et al., 2002) or EGFP (Kang et al., 2003; Wright et al., 2001); fluorescent
antigen-specific T cells are generated by crossing these mice with OT-II TCR
transgenics.
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Mice are injected with two types of T cell, both antigen-specific (EGFP-OTII)
and non-specific ECFP-expressing CD4+ T cells, to provide an internal control in each
imaging field. After image acquisition, movement parameters described below are
analyzed quantitatively in order to determine how the cells are interacting.

Analysis of cell motility parameters
The position of each cell was tracked in three dimensions over time, and
displacement and motility parameters were calculated for each cell. These include
measurements of cell velocity, cell directionality, and cell-cell contact duration,
information that can only be acquired by directly visualizing the interacting cells. Both
instantaneous measurements and per-cell average measurements of velocity and
immobility are taken; the percent of each track during which cells are immobile is termed
the arrest coefficient (Hugues et al., 2004). “Immobile” was defined as average or
instantaneous velocity less than 2 µm/min, as dendritic cells that appeared to be entirely
stationary had measured velocities of up to 2 µm/min. The motility coefficient is the
slope of the linear portion of the curve obtained when mean displacement is plotted
against the square root of time, and is analogous to the diffusion coefficient of a particle
exhibiting Brownian motion (Mempel et al., 2004; Sumen et al., 2004). Measurements of
directionality include the confinement index and turning angle. The confinement index is
the ratio of the maximum displacement to the total path length, and reflects the
directionality of cell movement over the entire path (Hugues et al., 2004). The turning
angle between velocity vectors at subsequent timepoints provides an instantaneous
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measure of directionality (Mempel et al., 2004). As a general rule, arrested cells move
less directionally than freely moving cells; naïve T cells tend to move in relatively
straight lines.
Cell confinement and pausing are also analyzed. Cells which move freely in a
random-walk pattern exhibit a linear relationship between their displacement and the
square root of time, while cells that move directionally have a displacement directly
proportional to time (Sumen et al., 2004). Cells that are confined within a smaller
volume reach a displacement plateau, indicating that their movement is limited. To
examine cell-cell interactions, the duration of cell-cell contacts can be measured
manually; the time a cell spends paused can be analyzed as a function of distance to
another cell, to determine if relationships exist.

Tolerized T cells rapidly undergo an antigen-specific arrest
At the first time point examined, 1-6 h after transfer, we observed that tolerized
OT-II cells arrested, while control nontransgenic T cells did not (Figure 4.4; Movie 4.1).
The tolerized T cells moved at an average velocity of 4.4 µm/min, while control nontransgenic T cells moved at 9.4 µm/min (Figure 4.4, p < 0.001). As compared with
nontransgenic T cells, more of the specific T cells were arrested for the duration of the
imaging period, and specific cells had a higher arrest coefficient, 47% v. 20%, p <
0.0001; Figure 4.5). Consistent with their relative immobility, specific cells moved less
directionally, as shown by their higher turning angle (82° v. 61°, p < 0.0001) and lower
confinement index (41% v. 56%, p < 0.0001; Figure 4.6. As controls, we injected mice
with isotype control-targeted Ova (III/10-Ova) and irrelevant peptide -Dec-CSP
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antibodies and imaged the T cell response; antigen-specific OTII T cells did not arrest,
and moved indistinguishably from nontransgenic T cells.
At the second time point examined, between 6-12 h, specific T cells remained
significantly slower than non-specific T cells, but were moving faster than in the first 1-6
h (5.94 µm/min v. 7.5 µm/min, p < 0.001; Figure 4.4; Movie 4.2). Antigen-specific T
cells were more immobile (12% v. 6%, p < 0.05; Figure 4.5), with a larger arrest
coefficient (32% v. 13%, p < 0.0001; Figure 4.5) and moved less directionally, with a
lower confinement index (53% v 66%; Figure 4.6). At the third time point examined,
from 12-18 h, specific T cells were still significantly slower (7.0 v. 8.8 µm/min, p.
0.0001; Figure 4.4; Movie 4.3) and more immobile (12% v. 3%, p < 0.002); Figure 4.5),
but had no significant differences in the directionality of their movement (Figure 4.6).
To determine if the differences seen between the various imaging intervals was
significant, we performed two-way analysis of variance (ANOVA). The ANOVA
indicated that the difference in speeds between the antigen-specific OT-II cells and the
nontransgenic control cells was significantly greater at 1-6 h than at either 6-12 h or 1218 h (p < 0.0001 for both). Additionally, the difference between 6-12 h and 12–18 h was
not significant, suggesting that the tolerized T cells are recovering mobility by 6-12 h.

Priming yields an antigen-specific arrest similar to that observed in tolerance
To visualize the immune response under pro-inflammatory conditions, we
delivered antigen to DCs in the presence of an -CD40 antibody as an adjuvant, and
transferred T cells and imaged as above. We observed that primed cells, like tolerized
cells, arrested antigen-specifically shortly after their exit into LNs (Figure 4.7; Movie
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4.4). In the first time period imaged, from 1-6 h after T cell transfer, specific T cells
moved at an average speed of 5.2 µm/min, slower than that of the control T cells (8.8
µm/min; Figure 4.7). The specific cells were more immobile (31% v. 10%, p < 0.0001;
Figure 4.8), and had a higher arrest coefficient (40% v. 21%, P < 0.0001; Figure 4.8),
and moved less directionally (Figure 4.9). In the second time period imaged, from 6 –
12 h after T cell transfer, specific T cells remained slower than non-specific cells (4.4 v.
8.0 µm/min, p < 0.0001; Figure 4.7; Movie 4.5), and had a higher arrest coefficient (46%
v. 27%, p < 0.001; Figure 4.8), but were no longer significantly more immobile (Figure
4.8). Measures of directionality were also mixed – OT-II T cells showed a smaller
confinement index (40% v. 49%, P < 0.02; Figure 4.8), but no significant difference in
turning angle. In the third time period imaged, from 12–18 h, the primed T cells moved
slightly more slowly (6.1 v. 7.5 µm/min, p < 0.005; Figure 4.7; Movie 4.6) and had
slightly higher arrest coefficients (35% v. 28%, p < 0.05; Figure 4.7), but all other
movement parameters were indistinguishable. Two-way ANOVA showed that the speed
difference between OT-II cells and nontransgenic T cells was significantly smaller in 1218 h than at 1-6 h (p < 0.003) and at 6-12 h (p < 0.006), while there was no difference
between 1-6 h and 6-12 h.
We observed that in both tolerance and immunity, naïve T cells arrested antigenspecifically shortly after leaving HEVs (Figure 4.2; Movies 4.1, 4.4). Tolerized T cells
recovered marginally faster than primed T cells, but both had recovered significantly by
12-18 h (Figures 4.4, 4.7; Movies 4.3, 4.6). The pattern of an early arrest followed by
restoration of mobility is also observed if the non-specific T cells are used as internal
controls, and T cell speed is normalized to that of the control cells in each imaging field
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(Figure 4.10); this permits more reproducible comparison between separate imaging
fields from independent experiments.
We occasionally observed discrete T cell swarms or clusters forming around DCs,
(Movie 4.7), but did not always observe arrested T cells in contact with EYFP+ DCs
(Movie 4.8), perhaps because some DC processes are too thin to visualize. Although
infrequently observed, these clusters were seen under both conditions of tolerance and
immunity.
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Figure 4.1. OT-II T cell activation and tolerance induced by -DEC-OVA.
Transferred OT-II T cells (CD45.2) divide in response to antigen presented by DCs in
vivo by day 3 and are deleted in the absence of -CD40 by day 7. (a) Similar activation
of OT-II T cells after delivery of -DEC-OVA with and without -CD40. Histograms
show surface expression of the indicated marker gated on CD45.2+ TCR V2+ cells 3, 12,
and 24 hours after challenge (see Methods). (b) Plots show CFSE dye dilution of gated
populations of CD4+ CD45.2+ T cells 3 and 7 days after challenge with 2 g of -DECOVA with or without -CD40 or with PBS. Percentages of CFSEhi/lo TCR V2+ cells out
of CD4+ T cells are indicated. (c) Numbers of surviving OT-II cells 3 or 7 days after
challenge as in (b); percentages of CD45.2+ TCR V2+ cells among CD4+ T cells are
indicated. Antigen-specific T cells were deleted unless CD40 was engaged. (d) OT-II
cells are only transiently activated by in vivo delivery of -DEC-OVA to DCs. CD4+
cells were purified from peripheral LNs 3 or 7 days after challenge as in (b) and cultured
with irradiated CD11c+ cells in the presence or absence of OVA peptide; proliferation
index denotes the ratio of thymidine incorporation in antigen-challenged to unchallenged
cells, corrected for background proliferation.
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Figure 4.2. During early stages of priming and tolerance, antigen-specific T cells are
located closer to HEVs in the superficial paracortex than non-specific T cells. (a)
Confocal micrographs of LN frozen sections immunostained for MECA-79 (red) and
B220 (blue); EGFP fluorescence from transferred T cells (green) was visualized directly.
EGFP-expressing OTII or non-TCR transgenic T cells were transferred into C57BL/6
mice five hours after injection of -DEC-OVA with or without -CD40. Insets show
high-magnification view of T cells near HEVs (left panels) or in the deep paracortex
(right panels); the deep paracortex is outlined in yellow. Optical sections were 1.2 m in
both MECA-79 and B220 channels and 5 mm in the EGFP channel. (b) The percentage
of T cells in the deep paracortex was calculated as in Bajenoff et al., (2003). Three hours
after cell transfer, there were more non-specific T cells found in the deep paracortex than
antigen-specific T cells; at 24 h after cell transfer, specific and non-specific T cells were
more equally represented in the deep paracortex. (c) The distance from T cells to the
nearest HEV was calculated as in Bajenoff et al. Three hours after cell transfer, antigenspecific cells were closer than non-specific cells to HEVs. Error bars denote standard
error of the mean. Asterisks indicate significant differences; see text for p values.
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Figure 4.3. Experimental timeline for imaging T cell tolerance and priming. CD11cEYFP mice were injected with -DEC-OVA with or without -CD40 5 h prior to transfer
of EGFP-OTII cells and wild-type ECFP-T cells; inguinal LNs were imaged intravitally
at the indicated periods. For histologic examination, WT C57/B6 mice were injected with
-DEC-OVA with or without -CD40 5 h prior to transfer of EGFP-OTII T cells or
EGFP T cells; LNs were harvested for histology at 3 or 24 h.
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Figure 4.4. T cell velocity under tolerizing conditions. Mice were injected with
antibodies and T cells, inguinal LNs were imaged, and specific and non-specific T cells
were tracked as above. Antigen-specific EGFP-OTII cells move slowly at 1-5 hours, with
a mean cell velocity of 4.4 m/min, while non-specific T cells maintain their normal
velocity of ~9 m/min. Error bars denote standard error of the mean. Asterisks indicate
significant differences; see text for p values.
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Figure 4.5. T cell arrest under tolerizing conditions. (a) Percent of immobile cells.
More antigen-specific EGFP-OTII cells than non-specific T cells are immobile (mean
velocity <2 m/min) at 1-6 hours. (b) Arrest coefficient of specific and non-specific T
cells. The arrest coefficient is the percentage of each track that a cell is immobile
(instantaneous velocity <2 m/min). From 1-6 hours after T cell transfer, tolerized EGFPOTII cells are arrested for an average of 40-50% of each track, as compared to 20% for
non-specific T cells. Error bars denote standard error of the mean. Asterisks indicate
significant differences; see text for p values.
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Figure 4.6: T cell directionality under tolerizing conditions. (a) Turning angle of
specific and non-specific T cells. Lower turning angles indicate more linear cell
movement. (b) Confinement index of specific and non-specific T cells. Confinement
index is the ratio of the maximum cell displacement to the path length; a higher
confinement index indicates more linear movement. At time points when antigen-specific
cells move more slowly than non-specific cells, the nonspecific cells move more linearly
by both measures of directionality. Error bars denote standard error of the mean.
Asterisks indicate significant differences; see text for p values.
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Figure 4.7. T cell velocity under priming conditions. Mice were injected with
antibodies and T cells, inguinal LNs were imaged, and specific and non-specific T cells
were tracked as above. Primed antigen-specific EGFP-OTII cells move slowly at 1-5
hours, with a mean cell velocity of 5.2 m/min, while non-specific T cells maintain their
normal velocity of ~9 m/min. Error bars denote standard error of the mean. Asterisks
indicate significant differences; see text for p values.
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Figure 4.8. T cell arrest under priming conditions. (a) Percent of immobile cells. More
antigen-specific EGFP-OTII cells than non-specific T cells are immobile (mean velocity
< 2 m/min) at 1-6 hours. (b) Arrest coefficient of specific and non-specific T cells. The
arrest coefficient is the percentage of each track that a cell is immobile (instantaneous
velocity < 2 m/min). From 1-6 hours after T cell transfer, primed EGFP-OTII cells are
arrested for an average of 40-50% of each track, as compared to 20% for non-specific T
cells. Error bars denote standard error of the mean. Asterisks indicate significant
differences; see text for p values.
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Figure 4.9: T cell directionality under priming conditions. (a) Turning angle of
specific and non-specific T cells. Lower turning angles indicate more linear cell
movement. (b) Confinement index of specific and non-specific T cells. Confinement
index is the ratio of the maximum cell displacement to the path length; a higher
confinement index indicates more linear movement. At time points when antigen-specific
cells move more slowly than non-specific cells, the nonspecific cells move more linearly
by both measures of directionality. Error bars denote standard error of the mean.
Asterisks indicate significant differences; see text for p values.
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Figure 4.10: Speeds of antigen-specific cells normalized to speed of control cells in
the same imaging field, under tolerizing and priming conditions. Cells were
transferred, imaged, and tracked as above, and the median speed of the non-specific cells
was determined for each imaging field; fields with fewer than three non-specific cells
were excluded. Antigen-specific cell speeds were expressed as a percentage of the
median non-specific speed in the same field. Results are similar to those obtained for
mean cell velocity. Asterisks indicate significant differences; see text for p values.
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CHAPTER 5. PMHC POTENCY IN DC:T CELL INTERACTIONS

Much evidence suggests that TCR affinity for MHC II:peptide complexes
(pMHC) is significant in determining T cell fate in the periphery, not only during
thymocyte selection. To determine the role of TCR affinity in T cell responses, we used
the well-characterized moth cytochrome C system. Single point mutants of this peptide
have been generated, which disrupt the interaction with the AND TCR but have no effect
on binding to the I-Ek MHC II molecule (Kaye et al., 1989; Madrenas et al., 1995; Rogers
et al., 1998). As described above for the Ovalbumin peptide, we cloned the MCC peptide
and selected altered peptide ligands (APLs) into the C-terminus of an anti-Dec-205
antibody to target the peptide specifically to DCs. Mice were injected with Dec-APLs,
CFP-expressing AND T cells and GFP-expressing nontransgenic T cells were transferred,
and the resulting DC-T cell interactions were visualized by intravital microscopy.

pMHC potency correlates with activation and proliferation in vitro
Before performing any imaging studies, we first examined the effect of TCR
affinity for pMHC on T cell functional responses in vitro. Naïve T cells from AND mice
were cultured with irradiated DCs and graduated doses of soluble MCC or APL peptides;
L98A was found to be 10 to 50-fold more potent than WT MCC, Y97K was 1000-fold
less potent, and T102L showed no detectable response (Figure 5.1). To confirm that the
APLs were targeted to DCs and presented, we injected mice with Dec-APLs, purified
APCs, and assayed antigen presentation to T cells in vitro. DCs from targeted mice
induced strong T cell proliferative responses, while B cells and CD11c-CD19- cells from
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these mice did not induce T cell proliferation (Figure 5.2); this indicates that the DecAPLs are targeted to DCs and presented on I-Ek to T cells.

pMHC potency correlates with activation and proliferation in vivo
Before performing any imaging studies, we first examined the effect of TCR
affinity for pMHC on T cell functional responses in vivo. We injected mice with DecAPLs and measured T cell activation and proliferation. Injection of the isotype control
antibody III/10-targeted Ova, unmodified -Dec, or the irrelevant peptide -Dec-Ova
had no effect on T cell activation or proliferation, while injection of -Dec-MCC and all
the APLs induced upregulation of CD69 and downregulation of CD62L on AND T cells,
but not on polyclonal control T cells (Figure 5.3). T cell proliferation in vivo at 3 days
after transfer was similar to the in vitro proliferation measured above, with L98A yielding
more proliferation than MCC, yielding more than Y97K; no proliferation was observed
for T102L at day 3 (Figure 5.3). TCR affinity for pMHC therefore correlates well with T
cell proliferation in vivo.
In contrast to tolerance induction in the ovalbumin/OTII system (Figure 16), AND
T cells were not deleted by day 7 (Figure 5.3). We therefore isolated transferred T cells
after 7 d of antigen exposure in vivo and rechallenged them in vitro with MCC and
splenic DCs, to determine if the cells were anergized. At 7 days after challenge, all T
cells from -Dec-APL-treated mice were unresponsive to restimulation with MCC
peptide; only T cells from mice treated with PBS or MCC plus CFA proliferated in
response to antigen rechallenge (Figure 27).
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To confirm that the anergy observed on day 7 persisted in response to in vivo
rechallenge, we injected mice with -Dec-APLs, PBS, or MCC plus CFA and
rechallenged them on day 7 with MCC plus CFA. Only T cells from mice treated with
PBS or MCC plus CFA proliferated in response to this in vivo rechallenge; T cells from
mice treated with -Dec-MCC or -Dec-APLs did not proliferate or secrete IFN-
(Figure 5.4). Summarizing, we found that high-potency ligands (L98A) induce CD69
activation, IFN- secretion, and proliferation, medium-potency ligands induce CD69
upregulation and low levels of proliferation and IFN- secretion, and low-potency ligands
induce only CD69 upregulation. Even low-potency agonists unable of inducing T cell
proliferation are capable of anergizing T cells; T cell anergy induction therefore does not
require proliferation.

pMHC potency correlates with early antigen-specific T cell arrest
We next examined the effect of varying TCR affinity for pMHC on the in vivo
dynamics of DC:T cell interactions in inguinal lymph nodes of living mice. To visualize
dendritic cells, we used CD11c-EYFP mice as recipients, as above (Lindquist et al.,
2004); antigen-specific AND T cells expressed ECFP, while non-transgenic control T
cells expressed EGFP. We injected CD11c-EYFP mice with -Dec-L98A, -Dec-Y97K,
-Dec-T102L, or PBS and transferred T cells 5 h later; inguinal LNs were imaged
intravitally from 0.5 to 6 h or 6-12 h after T cell transfer.
We observed that pMHC potency correlated with early T cell arrest in response to
antigen. As observed for OT-II T cells in -Dec-Ova-treated mice, T cells arrested
antigen-specifically upon exposure to high-potency antigen (-Dec-L98A), slowing to a
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mean velocity less than half that of nontransgenic control T cells (Figure 5.5; Movie 5.1;
p < 0.001). Treatment with medium- and low-potency APLs, however, had no detectable
effect on T cell speed (Figure 5.5; Movies 5.2, 5.3). In addition to arresting, T cells
from mice injected with -Dec-L98A had significantly lower displacement rates and
were confined in significantly smaller volumes than were nonspecific T cells (Figure 5.5;
p < 0.001). Strikingly, no difference in any of the other movement parameters was
observed for the medium and low-potency APLs -Dec-Y97K and -Dec-T102L
(Figure 5.5), even though they had already begun to respond by upregulating CD69 and
downregulating CD62L (Figure 5.3).
To determine if the medium- and low-potency antigens had any effect on T cell
behavior at later time points, we also imaged inguinal LNs from mice injected with Dec-APLs at 6-12 h after T cell transfer. In mice injected with -Dec-L98A, we found
that antigen-specific T cells had recovered their mobility and moved with the same
average velocity as control cells; other movement parameters were also no different than
for control T cells (Figure 5.5). Interestingly, antigen-specific T cells from mice treated
with medium and low-affinity -Dec-Y97K and -Dec-T102L remained unaffected by
antigen exposure, moving indistinguishably from control T cells (Figure 5.5).
As it is known that activated T cells are sequestered in LNs for a short period after
activation, we examined T cell trapping in LNs as a function of TCR affinity for pMHC.
We injected mice with -Dec-APLs, transferred equal numbers of AND and WT
nontransgenic T cells, and examined the ratio of AND to WT T cells in blood at 24, 48,
and 72 h post T cell transfer. We observed that all APLs induced significant trapping of
AND T cells and not control cells for 48-72 h post injection, with the ratio of AND cells
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to control cells returning to unity at 3 d for Y97K and T102L and by 4 d for L98A
(Figure 5.5).

pMHC potency correlates with Ca2+ flux in vitro
It is known that TCR signaling rapidly leads to an increase in intracellular
calcium (Negulescu et al., 1996), and it was recently shown that elevated intracellular
Ca2+ is necessary and sufficient to stop thymocyte migration in explanted thymic slices
(Bhakta et al., 2005). We therefore investigated the role of calcium signaling in pMHCdriven T cell arrest. We first performed in vitro studies, measuring the Ca2+ flux in
preactivated T cell blasts in response to GPI-anchored I-Ek:MCC variants incorporated
into lipid bilayers. Activated T cells moved rapidly and had a low basal Ca2+
concentration on bilayers incorporating only ICAM-1 or ICAM-1 plus irrelevant I-EkpMHC (Figure 5.6; Movie 5.4). Activated T cells on bilayers with I-Ek-L98A elicited a
strong Ca2+ flux and had a significantly decreased mobility (Movie 5.5), while T cells on
bilayers with the medium-affinity agonist I-Ek-Y98K exhibited only a minimal increase
in Ca2+ over controls (Movie 5.6), and cells incubated with low-affinity I-Ek-T102L were
indistinguishable from control cells in terms of Ca2+ flux or mobility (Figure 5.6; Movie
5.7).
To rule out the possibility that the lack of signaling induced by low-potency APLs
was due to the absence of costimulatory molecules normally present on DCs but absent
from the lipid bilayers, we measured Ca2+ flux in naïve T cells interacting with CD11c+
DCs isolated from the LNs of -Dec-APL targeted mice. Consistent with the results
observed on lipid bilayers, only the high-affinity agonist L98A was able to induce
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significant Ca2+ signaling (Figure 5.7). We therefore conclude that TCR affinity for
pMHC is correlated with the extent of Ca2+ flux in vitro and with T cell stopping upon
exposure to antigen.

pMHC potency correlates with Ca2+ flux in vivo
To determine if these conclusions held true in vivo, we labeled naïve AND T cells
with the Ca2+-sensitive dye Fluo-4-AM and visualized Ca2+ responses in inguinal LNs of
living mice using confocal microscopy. To exclude any spurious Ca2+ flux, we included
only cells that had clearly extravasated from HEVs. Additionally, we defined a
“sustained” Ca2+ response as an increase 1.5 times over the average response in control T
cells; on the basis of in vitro calibration, we estimate that an increase of 1.5-fold in
fluorescence corresponds to 1.8-fold increase in intracellular Ca2+, which is sufficient to
cause T cell stopping in vitro (Negulescu et al., 1996).
In mice injected with irrelevant peptides, we observed that only 5% of AND T
cells showed sustained Ca2+ increases, while injection of -Dec-L98A led to a sustained
Ca2+ flux in 30% of AND T cells (Figure 5.8; Movies 5.8, 5.11, p < 0.0001). In contrast,
injection of -Dec-Y97K or -Dec-T102L both led to sustained Ca2+ flux in only 2% of
AND T cells, not significantly different from the controls (Figure 5.8; Movies 5.9, 5.10).
Additionally, the high-affinity ligand L98A induced higher levels of Ca2+ flux than did
the medium and low-affinity ligands Y97K and T102L (Figure 5.8). Only -Dec-L98A
induced a significant decrease in T cell speed (as was observed in the T cell response to
ovalbumin (Figure 4.4)), with -Dec-Y97K and -Dec-T102L having no effect. We
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therefore conclude that in vivo Ca2+ flux is induced by high-potency pMHC ligands and
leads to T cell arrest.
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Figure 5.1. Differential activation of CD4+ AND T cells by APLs. (a,b) Naive CD4+
T cells from AND mice (3 x 105 / well) were cultured with irradiated DCs (3 x 104 / well)
and varying doses of soluble peptides in triplicate. (a) Proliferation measured by (3H)
thymidine incorporation between 60 and 72 h with data representing the mean c.p.m.
from triplicate cultures. (b) IFN- production measured by Elispot assay under the same
conditions.
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Figure 5.2. Anti- DEC delivers antigen to DCs in vivo. B10.BR wild type mice were
injected subcutaneously in the footpads with 10 g of -DEC-MCC, -DEC, Iso-MCC,
-DEC or PBS as indicated. CD11c+, CD19+, and CD11c–CD19– cells were isolated from
draining LNs 24 h after antibody injection and assayed for antigen processing and
presentation to purified AND T cells in vitro. T cell proliferation was measured by (3H)
thymidine incorporation, and is expressed as a proliferation index relative to PBS control.
The results are means of triplicate cultures from one of three similar experiments. Similar
results were obtained using -DEC-APLs.
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Figure 5.3. Activation of AND T cells in vivo by -DEC-MCC and -DEC-APL
constructs. (a) Flow cytometry of CD69 and CD62L surface expression on AND
transgenic T cells adoptively transferred into B10.BR mice 5 h after subcutaneous
footpad injection of -DEC-MCC and -DEC-APL constructs, -DEC-ovalbumin (DEC-OVA), isotype-MCC plus -DEC-205 (-DEC + iso-MCC) or PBS. Cells were
gated on CD45.2 and V11V3 and analyzed at 3 and 72 h after challenge. (b,c)
Proliferation assay of AND T cells adoptively transferred into B10.BR mice 24 h after
subcutaneous footpad injection of -DEC-MCC, -DEC-APL constructs (-DEC + isoMCC), -DEC-OVA or PBS, assayed by CFSE dilution in gated populations of CD4+
and V11+V3+ T cells at 3 and 7 d after antibody injection. (c) Percent of
CD45.2+V11+V3+ cells with low (Divided) or high (Undivided) fluorescence intensity
of CFSE among CD4+ T cells. Data are representative of three independent experiments.
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Figure 5.4. Proliferation is not required for the induction of T cell anergy in vivo. (a)
TCR-transgenic mice were injected with 10 µg -DEC-MCC or -DEC-APL, 100 µg
MCC in CFA, or PBS, followed by isolation and restimulation of cells with or without
rechallenge of mice with MCC as described below. (b–d) CFSE dilution analysis of
proliferation. (b,c) Analysis of CFSE-labeled CD4+ cells isolated and restimulated with
irradiated CD11c+ DCs in the presence (CFA + MCC) or absence of MCC on day 3 (b) or
day 7 (c) after the injection described in a. (d) Analysis of cells from mice systemically
rechallenged with 100 µg MCC in CFA on day 7 after the injection described in a; 3 d
later, CD4+ cells were purified and restimulated as described in b,c. (e–g) Enzyme-linked
immunospot assay of IFN- production. (e,f) Analysis of cells treated as described in b,c
on day 3 (e) or day 7 (f) after antigen injection as described in a. (g) Analysis of cells
from mice treated as described in d. Data are representative of three to four experiments.
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Figure 5.5. Potency of the pMHC complex drives early T cell deceleration. Analysis
of ECFP+ AND TCR-transgenic T cells (AND-CFP) or EGFP+ B10.BR CD4+ T cells
(WT-GFP) adoptively transferred into CD11c-EYFP mice 5 h after injection with DEC-APL constructs or with PBS. (a,b) Tracks of antigen-specific and nonspecific T
cells after immunization with APLs, at 1–6 h (a) or 6–12 h (b). Axes represent 200 µm;
the tracking time was 20 min. Each graph represents cells tracked at the same imaging
field in one representative experiment. (c,d) Speeds of antigen-specific cells (filled
circles) and nonspecific cells (open circles) in the lymph nodes of mice exposed to
various APLs (horizontal axis). Speeds were measured along the entire cell tracks and are
normalized to the average speed of nonspecific cells moving in the same field during 1–6
h (c) or 6–12 h (d). Only the high-potency peptide L98A during the first 6 h significantly
slows the antigen-specific cells (p < 0.001). Small horizontal bars indicate means. (e)
Displacement rate of antigen-specific cells (filled bars) and nonspecific cells (open bars)
during hours 1–6 of treatment with antigen (horizontal axes); error bar represents s.e.m.).
(f) Confinement index of antigen specific cells (filled bars) and nonspecific cells (open
bars) imaged during hours 1–6 of treatment with antigen (horizontal axes); error bar
represents s.e.m.). (g,h) Displacement rate (g) and confinement index (h) analyzed as
described above for cells during hours 6–12 of treatment with antigen. Only the highpotency peptide L98A during the first 1–6 h significantly slows the antigen-specific cells
and confines them to a smaller volume (*, P < 0.001). Data are representative of a
minimum of three to four independent experiments per condition. (i) Retention of
activated T cells in vivo. Flow cytometry of surface expression of CD69 by a mixture of
CFSE-labeled AND TCR-transgenic and CMRA-labeled B10.BR CD4+ T cells
adoptively transferred into B10.BR mice 5 h after injection with -DEC-APLs, left
panel; the ratio of AND to wild-type (WT) T cells was measured in blood collected 24,
48, 72 and 96 h later, right panel. Data are representative of a minimum of three
independent experiments
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5.6 pMHC potency drives Ca2+ flux and arrest in vitro in T cell blasts. Calcium flux in
Fura-2-loaded, in vitro–activated AND T cell blasts on bilayers containing L98A-I-EK
(red), Y97K-I-EK (blue), T102L-I-EK (green) or no peptide-I-EK (black), at a density of 10
pMHC molecules per µm2, and glycosylphosphatidylinositol–ICAM-1 (300 molecules
per µm2). The Fura-2 ratio (emission with 340 nm excitation/emission with 380 nm
excitation (340/380)) was determined every 15 s after contact initiation; at the end of
each measurement, the ratio in response to ionomycin plus 10 mM CaCl2 (line at ratio =
1.7) and EGTA buffer containing 2 mM MgCl2 and 0 mM CaCl2 (line at ratio = 0.24) was
determined to obtain the upper and lower limits of Ca2+ measurement. (a) Single cell
traces. (b) Average responses. Each trace represents an average of 10–30 cells per
group, with the zero time point defined by time of contact determined by interference
reflection microscopy. (c) Speeds of the cells in a on the bilayer, calculated as total track
length divided by time of cell in the field. Each point represents the normalized mean
speed of a single cell; small horizontal bars indicate means for the entire cell population.
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Figure 5.7. pMHC potency drives Ca2+ flux and arrest in vitro in naïve T cells. (a)
Single cell Ca2+ flux in naïve T cells. CD11c+ DCs were purified from lymph nodes and
loaded with 100 M of L98A, Y97K, T102L or no peptide for 2 hours at 37 °C. Fura-2
labeled naive AND T cells were incubated with peptide-loaded DCs and the Fura-2 ratio
was determined as above. Shown are single cell Fura-2 ratios over the time course of
imaging for the different peptides. (b) Ca2+ flux and formation of T:DC conjugates.
CD11c+ DCs were purified from lymph nodes and loaded with APLs as above, then
incubated with Fura-2-labeled naive AND T cells. Figure represents percent of T cells
with a high cytoplasmic Ca2+ concentration forming conjugates with DCs; high Ca2+ was
defined as Fura-2 ratios above the mean ratio observed for no peptide. Numbers above
bars indicate total conjugates counted.
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Figure 5.8. pMHC potency drives Ca2+ flux and T cell arrest in vivo. AND T cells,
labeled with Fluo-4 calcium sensitive dye and CMRA, were adoptively transferred (15 x
106/mouse) into B10BR mice injected 5 h earlier with -DEC-APLs. Calcium signaling
in the inguinal lymph node was imaged in vivo for 2 h. (a) Twenty images taken at 30
seconds per frame were collapsed into one to show the path and calcium level of each cell
over time. Calcium level is pseudo-colored from cool to warm colors corresponding to
low to high Fluo-4 fluorescence (shown here normalized to CMRA fluorescence), see
color chart. (b) Number of T cells with elevated Ca2+ level in mice treated with -DECAPLs relative to that in control mice treated with isotype control antibody. Asterisk
indicates p < 0.0001. (c) Fluo-4-AM intensity of AND T cells in mice treated with DEC-L98A (red line), -DEC-Y97K (blue line), -DEC-T102L (green line) or isotype
control antibody (black line), presented as cumulative data points. (d) Speed of AND T
cells in the lymph nodes of mice treated with -DEC-APLs, measured along the entire
cell track and normalized to the average speed of AND T cells in mice treated with
isotype control antibody (Control). Each point represents one cell track; small horizontal
bars indicate means. Asterisk indicates p < 0.0004.
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CHAPTER 6. IMAGING GERMINAL CENTER REACTIONS

Humoral immunity is mediated by antibodies secreted from B cells. After being
released into the periphery, B cells can undergo secondary, antigen-dependent genetic
changes in specialized lymphoid structures called germinal centers (Jacob et al., 1991a;
Jacob et al., 1991b). Germinal center B cells (Fas+ GL7+) proliferate rapidly, with cell
cycle durations of 6-8 hours (MacLennan, 1994); as the cells proliferate, they express
high levels of AID, which deaminates the genes coding for the B cell receptor,
introducing somatic mutations (Di Noia and Neuberger, 2002; Ramiro et al., 2003). B
cells with newly mutated antigen receptors then compete with unmutated B cells and
other newly mutated B cells for antigen, on the basis of their B cell receptor’s affinity for
the antigen. High-affinity cells outcompete lower-affinity cells, with the higher affinity
cells continuing to proliferate, and the low-affinity cells dying by apoptosis.
However, none of this had been directly observed in living germinal centers – all
of the previous studies used fixed sections. We thus decided to investigate the cellular
dynamics of germinal center reactions using the same microscopy techniques we had
previously established. Transgenic mice with antigen-specific B cells had previously
been generated in the lab(Shih et al., 2002a; Shih et al., 2002b); in conjunction with 
light chain, their B cells bind to nitrophenol (NP) antigen. These B1-8hi mice were bred to
mice that expressed GFP ubiquitously. We transferred GFP-expressing NP-specific B
cells into mice previously primed with ovalbumin, boosted the mice with NP-conjugated
ovalbumin, and imaged germinal centers six days later; this transfer protocol yielded an
average frequency of 0.2% NP-specific B cells in the mouse (Figure 6.1). FACS and
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histology indicated that GC B cells (Fas+GL7+) were formed by day 3, and GCs were
organized into dark and light zones by day 6 (Figure 6.2). As internal controls,
nontransgenic CFP-expressing B cells were transferred 24 h prior to imaging; we
visualized follicular dendritic cells by s.c. injection of a fluorescently-labeled anti-FDCM1 antibody (Figure 6.3)(Kosco et al., 1992; Szakal et al., 1988). The FDC-M1 antibody
largely labels follicular dendritic cells, but also reacts with CD68+ tingible body
macrophages; tingible body macrophages can be readily distinguished from FDCs by
their large cell bodies and lack of processes (Figure 6.3). Inguinal LNs were imaged as
above in our previous studies of DCs and T cells, but at shallower depths, since B cell
follicles and GCs are more superficial than the T cell areas.
Our first observations of germinal centers revealed that GC B cells moved
vigorously throughout the GC, as did nontransgenic control B cells (Movie 6.1). Outside
the B cell follicle, we observed sessile, round cells; histologic examination indicates that
these are plasma cells in the LN medulla (Movie 6.1). However, when every cell in the
GC expressed GFP, the cells were too densely packed to follow and track individually.
Therefore, we transferred a mixed population of GFP+ and GFP- B1-8hi B cells; the best
results were obtained with approximately 10-15% of the B1-8hi cells expressing GFP –
individual cells were easily distinguished and followed, and large numbers of cells were
seen in each GC (Movie 6.2).

GCs are open structures in which antigen-specific B cells are retained
In the absence of antigen, we observed that both B1-8hi and nontransgenic B cells
moved throughout the B cell follicle and the light zone of the GC, while being largely
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excluded from the dark zone (Figure 6.4; Movie 6.3). There was no significant
difference in between the movement of control and transgenic B cells in any of the
analyzed motility parameters: average velocity, displacement rate, confinement index,
turning angle, arrest coefficient, maximum pause duration, or motility coefficient (Figure
6.4). In the absence of specific antigen, both transgenic B1-8hi and nontransgenic B cells
move with a mean velocity of ~8 µm/min, about 80% as rapidly as naïve T cells
(typically ~10 µm/min) through both the FDC-rich light zone and the rest of the B cell
follicle.
After boosting with NP-Ova, we observed that B1-8hi GC B cells are largely
restricted to the GC area defined by the FDC, while the size and behavior of
nontransgenic B cells was unchanged (Figure 6.4; Movie 6.2). The NP-specific GC B
cells were visibly larger than nontransgenic cells, with a two-fold increased volume; they
moved more slowly, with less directionality and longer maximum pause durations
(Figure 6.4). The motility coefficient – a measure of the volume scanned, analogous to a
particle’s diffusion coefficient – was reduced from 30 µm2/min to 13 µm2/min in the
presence of specific antigen, indicating that NP-specific GC B cells are confined to a
smaller volume than nontransgenic B cells or B1-8hi cells in the absence of antigen. To
ensure that our FDC-M1 antibody was not interfering with antigen binding by FDCs, we
imaged in the absence of FDC-M1 labeling and saw no differences in any movement
parameter (Movie 6.4).
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There is no net B cell migration between GC light and dark zones
We next examined B cell migration within and between GC light zone and dark
zones. The net displacement vector for B1-8hi and nontransgenic B cells was less than a
cell diameter after 30 min of observation, indicating that there is no significant directional
bias to B cell migration. We observed that 8% of the dark zone GC B cells migrated to
the LZ and 5% of light zone GC B cells migrated to the dark zone after 30 min; once
corrected for the increased B cell density of the dark zone, there is no significant
difference (Figure 6.5). This rate of inter-zone movement implies complete exchange
between GC dark and light zones within 18 h, consistent with a model of GC selection
that involves multiple rounds of cycling between light and dark zones.

GC B cells decelerate upon making antigen-specific contacts but do not arrest
To characterize the interactions between FDCs and B cells, contacts between
FDC-M1+ cells and B1-8hi GC B cells or nontransgenic B cells were measured by hand.
On average, 30% of control B cells contacted an FDC-M1+ cell in each 30 min
observation period; their contacts were significantly shorter than those of the B1-8hi B
cells (2.3 v. 3.5 min, p < 0.001; Figure 6.6; Movies 6.5, 6.6). In addition, GC B cells in
contact with FDC-M1+ cells moved more slowly than cells not in contact with FDC-M1+
cells (5.6 µm/min v. 7 µm/min; Figure 6.6), but did not arrest. Antigen-specific GC B
cells were more associated with FDCs than were control nontransgenic B cells, which
seemed almost to ignore FDCs (Movies 6.5, 6.6).
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B cells compete on the basis of affinity for antigen to join ongoing GC reactions
The fact that nontransgenic, polyclonal B cells were found within NP-boosted
GCs, and that transgenic NP-specific B cells were found in Ovalbumin GCs indicates that
naïve B cells are not excluded from GCs on the basis of antigenic specificity. This shows
that the germinal center is an open structure, with no physical barrier preventing naïve or
recirculating B cells from entering. We investigated whether B cells could join an
ongoing GC reaction by transferring B1-8hi GC B cells 6 or 9 days after boosting, and
found that they successfully joined GCs and participated in the GC reaction (Figure 6.7).
To examine the role of affinity in germinal-center joining, we took advantage of the B18lo mouse, a heavy-chain knock-in with 40-fold lower affinity for NP. We transferred
B1-8hi B cells into WT mice, B1-8lo mice, and B1-8hi mice immunized with Ovalbumin
and boosted with NP-Ova six days prior to transfer (Figure 6.7). We found that B1-8hi
cells efficiently joined GCs in WT (19/21) and in B1-8lo mice (25/25), but not in B1-8hi
mice (0/18), indicating that B cells can join pre-existing GC reactions when they have an
advantage in antigen-binding affinity (Figure 6.7). GC reactions are therefore
continually scanned, with continuous competition on the basis of affinity; the
implications of this with regard to B cell memory and epitope spreading are discussed in
the next chapter.
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Figure 6.1. Transferred B cell frequency and oligoclonal generation of GCs. (a)
Flow cytometric analysis of splenocytes. 2 x106 B1-8hi, +, GFP+ B cells, were transferred
into B6.SJL immunized with Ova in alum. B cell chimerism was assed by FACS after
gating on CD19+ cells. Upper panel shows histogram of GFP expression. Numbers
indicate percentage of total CD19+ cells which are also GFP+. Lower panel shows dot plot
of GFP versus Ig expression after gating on all CD19+ cells. GFP+ cells were Ig
expressing. Numbers indicate percentage of total CD19+ cells. (b) Oligoclonal generation
of GCs. A mixture of B1-8hi B6.SJL and B1-8hi, GFP+ B6.SJL B cells (9:1 mixture, 2 x
107 total CD43- B cells) were transferred into OVA/alum-primed B6 hosts. Boosting was
carried out by s.c. injection of NP-OVA. Lymph nodes were harvested 6 days after the
boost. FACS histogram gated on CD45.1+ transferred cells reveals that 10% of the
transferred cells were GFP+ cells. (c) Lymph node section (GFP (green), CD45.1 (red),
B220 (blue)) showing GC composition. (d) Zoom on single GC representative for
difference in GFP+ B cells density. All transferred B cells are stained with CD45.1 (red)
and GFP+ fraction is displayed in green. When 10% of the antigen specific B cells were
GFP labeled B cells, the percentage of GFP+ B cells in GC varied and 2 out of 39 GC (5
%) did not contain any GFP+ B cell. When a higher percentage of GFP+ B cells were
transferred, all GC contained GFP+ B cells (data not shown). With lower percentages of
labeled B cells we did not reliably see labeled cells in GCs. We conclude that under
these conditions GC are established out of about 10 clones.
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Figure 6.2. Flow cytometric and histological analysis of NP/B1-8hi GC kinetics. (a)
Flow cytometric analysis. B1-8hi B6.SJL B cells were transferred into OVA/alum-primed
B6 hosts. Boosting was carried out by s.c. injection of NP-OVA. Draining lymph nodes
were harvested 0, 3, 6, 10, 14, 18 days after boosting. FACS profiles were gated on
CD45.1 and B220 expressing live lymphocytes. Numbers in the upper right corner
indicate the percentage of Fas+ and GL7+ gated cells. GL7+ and Fas+ cells developed by
day 3 and were detectable up to 18 days after boosting. (b) Flow cytometric analysis.
B1-8hi B6.SJL B cells were transferred into OVA/alum-primed B6 hosts. Boosting was
carried out by s.c. injection of NP-OVA. Popliteal lymph nodes were harvested 4, 6, 10,
14, and 18 days after the boost. Histological sections were stained with CD45.1 (green),
IgD (blue), PNA (red). Transferred cells developed into PNA+ B cells and were visible in
clusters as early as day 4 after boosting. After 6 days GC organized in DZ and LZ and
were detected up to 18 days after boost
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Figure 6.3. FDC-M1 in vivo staining. For in vivo labeling (a-d) of FDCs, FDC-M1
antibody or rat IgG2b was injected s.c.. Inguinal and popliteal lymph nodes were
harvested 16 hours later. Histological sections were stained with anti-CD35 (green) and
anti-IgD (blue) (a and c), or with anti-CD68 (green) and anti-IgD (blue) (b and d). FDCM1 in vivo staining co-localized with CD35 immuno-fluorescent staining, but also colocalized with CD68 positive macrophages (tingible body macrophages). Isotype control
doesn’t stain GCs. (e-f), Histological staining of day 6 GCs with anti-IgD (blue), antiCD35 (e) or FDC-M1 (f) (red) and CD68 (green). TBM are visible in the DZ and LZ of
the GC. FDC-M1 partially co-stains with CD68. We find a good coincidence of CD35 (a
light zone marker) and FDC-M1 staining. We do see coincidence of tingible body
macrophages with FDC-M1 and CD68 and these cells are found in the DZ as well as LZ
but they do not interfere with the distinction between DZ and LZ because of the relative
density of staining in the two regions. Furthermore, tingible body macrophages are
clearly distinguished from the FDC network by their large cell bodies and relative lack of
processes.

118

a

b
CD35

FDC-M1 sc

CD68

IgD

IgD

c
CD35

FDC-M1 sc

d
rat IgG2b sc

CD68

IgD

rat IgG2b sc

IgD

e

f
CD68

IgD

CD35

CD68

IgD

FDC-M1

Figure 6.4 Behavior of GC and naïve B cells in secondary follicles. (a) Timeline for
immunization, cell transfer and imaging. (b) Diagram showing the region of the inguinal
lymph node that was imaged in vivo (right, G: GC, B: B cell follicle, T: T cell zone, I:
interfollicular zone, M: medulla) and dimensions of time-lapse still (left). (c) Time-lapse
still z projection of FDC signal (red) superimposed with tracks of B1-8hi (green, upper
row) and control (blue, middle row) B cells. Two representative movies with (right) and
without (left) antigen boost are displayed. (d, e) Quantitative analysis of WT and B1-8hi
B cells in the presence (right; WT: 534 cells, B1-8hi: 311 cells) and absence (left; WT:
212 cells, B1-8hi: 200 cells) of specific antigen. Analysis is based on 3 independent
experiments for both conditions (d) Random walk analysis in the absence (left) and
presence of NP-OVA (right). Displacement values are averaged for all B1-8hi (green) and
WT (blue) B cells. From the slope (x/t1/2) of the linear segment (R2=0.99) the motility
coefficient (M = x2/6t) was calculated, which is a measure of the volume scanned by a
cell per time interval. Error bars represent standard error. (e) Statistical analysis of cell
behavior. Each data point represents a value for a single cell and black horizontal bars
represent mean values. A parametric test (ANOVA) followed by Bonferroni multiple
comparison test was performed. Only cell volumes from cells within the same movies
were tested for differences (unpaired two-tailed t-test). Samples that are significantly
different from all other samples are marked with *** (p<0.001).
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Figure 6.5. Analysis of B cell behavior in GC LZ and DZ. (a) Time-lapse still
showing GC division into LZ and DZ and lymph node capsule is indicated as dashed line.
(b), Percentage of cells that were moving from the LZ to the DZ and the reverse within
30 minutes. 8% (n=188) moved from the DZ to the LZ and 5% (n=188) did the reverse
(upper panel). To correct for the different B cell density, the number of cells migrating
from DZ to LZ are shown as percentage of DZ cells (n=111) and the LZ to DZ
converting cells are shown as percent of LZ cells (n=77) (lower panel). (d) The arrest
coefficients (upper panel) and velocity (lower panel) for DZ and LZ B cells (green) are
shown separately in comparison to naïve control B cells (blue) (two-tailed t-test: arrest
coefficient p=0.03; velocity p= 0.08). The velocity is representative for all other
migratory parameters shown in Fig.1e. Analysis represents 4 different time-lapse movies
from 3 independent experiments. (e) Vector analysis. Displacement vector for all
antigen-specific B cells in GCs (upper panel) and all control B cells in B cell follicle
(lower panel) irrespective their initial position. The average net displacement vector is
displayed in red. (f) The magnitude of the average net displacement are shown for 4 time
lapse movies (3 independent experiments). (g) The angle of the average displacement
vector and a vector perpendicular to the lymph node capsule are shown for 4 time lapse
movies (3 independent experiments).
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Figure 6.6 Analysis of contacts between B cells and FDC-M1+ cells. (a) In vivo
observation of B cell FDC contact. Time-lapse images showing contacts between FDC
and GC B cell (lower row) and naïve B cell (upper row). White arrows indicates position
of B cell and cell tracks are displayed in blue and green for WT and B1-8hi B cell
respectively. (b) Instantaneous velocity profile during FDC-M1+ cell contact. Contact
duration is indicated by grey shading. Corresponding time points of stills in (a) are
indicated with black arrows. (c) Statistical analysis of B cell/FDC-M1+ cell contacts.
The contact duration between FDC-M1+ and follicular (blue dots) or GC B cells (green
dots) was retrieved from time-lapse movies. Each dot represents a contact (p < 0.0001,
unpaired t-test two-tailed). (d) Cell velocity of follicular and GC B cells in contact with
FDC-M1+ cells (grey shading) or not (WT: p = 0.26; B1-8hi: p < 0.0001, paired t-test).
Analysis is based on two independent experiments and 3 time-lapse movies.
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Figure 6.7 B cell entry into ongoing GC reactions is affinity-dependent. (a) Timeline
of immunization (top) and B cell transfer (bottom). B cells were transferred 0, 6, or 9
days after the NP-OVA boost. (b) Histological sections of lymph nodes harvested 6
days after B cell transfer stained with PNA (red), IgD (blue) to label GC B cells and
naïve B cells respectively. Transferred B cells were GFP+ (green). In 2 experiments,
when cells were transferred with the boost (0 d), we analyzed 25 GCs of which 22 were
composed entirely of transferred B cells. In four experiments, when cells were transferred
6 or 9 days after the NP-OVA boost, we analyzed 44 GCs of which 38 were mixed. (c)
Timeline of immunization and B cell transfer. WT (B6.SJL), B1-8lo, and B1-8hi recipient
mice were immunized with Ova and boosted with NP-Ova as in all previous experiments.
B1-8hi B cells were transferred into the immunized mice 6 days after the boost. (d)
Histological sections of lymph nodes harvested 6 days after B cell transfer stained with
PNA (red), IgD (blue) to label GC B cells and naïve B cells respectively. Transferred B
cells were GFP+ (green). B1-8hi B cells only joined GCs in WT (B6.SJL) and B1-8lo mice,
and therefore joining is dependent on BCR affinity. In 3 experiments, when cells were
transferred in B1-8lo mice, we analyzed 25 GCs all of which were mixed. In 3
experiments, when cells were transferred in B1-8hi mice, we analyzed 18 GCs all of
which were composed of endogenous B cells. (e) Flow cytometric analysis of GCjoining B cells. OVA-immunized B6 mice were boosted with NP-OVA. B1-8hi SJL B
cells were either transferred together (0 days) or 6 days after the NP-OVA boost (-6
days). (f) Proliferation of transferred B cells was measured 1, 2, and 3 days after B cell
transfer by CFSE dilution. Percentages indicate divided cells. (g) GL7 and Fas
expression 6 days after B cell transfer (gated on CD19+ and CD45.1+). Percentages
indicate FAS+ and GL7+ cells.
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CHAPTER 7. DISCUSSION

T cell Antigenic Search Algorithm
For naïve T cells to promptly respond to pathogens requires that they survey
antigenic space effectively; this in turn requires that antigens be rapidly delivered to the
LN and the full range of antigenic pMHC be made available to T cells. We observed that
DCs in the T cell area form a dense network of cells whose processes extend throughout
the entire paracortex. The majority of these DCs do not show significant translational
movement, instead remaining largely stationary while extending their dendrites in
probing motions (Figure 3.4; Movie 3.9). Higher-order clusters of DCs, T cells, and B
cells were seen at the interface between the B and T cell areas (Figure 3.5, 3.6; Movie
3.13); based on their cellular composition and location, we speculate that they are the
physical correlates of T cell help. Newly emigrated DCs distribute themselves throughout
the T cell area and integrate into the existing DC network; as they become more settled,
their probing motions replace translational movement (Figure 3.7; Movie 3.16). It has
been shown that the extensive movements of DC processes enable DCs to contact up to
5,000 T cells per hour (Miller et al., 2004a); this “probing” movement is dependent on
the small GTPases Rac1 and Rac2, which are necessary for proper antigen presentation
(Benvenuti et al., 2004). The T cell antigenic search mechanism is largely driven by T
cell motility through a network of probing dendritic cells; we speculate that the higher
motility of mature DCs functions to distribute dendritic cells throughout the paracortex.
We further speculate that this change from “mobile” to “sessile” phenotypes is necessary
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for appropriate interaction with migrating T cells and therefore for proper antigen
presentation.
In the steady state, the DC network presents migrating T cells with an enormous
surface area rich in self pMHC complexes required to sustain T cell longevity (Kirberg et
al., 1997; Takeda et al., 1996) and to maintain self-tolerance. Both self and non-self
antigen delivered to the LN via the lymph are processed simultaneously by many DCs in
the network (Belz et al., 2004; Inaba et al., 1997; Inaba et al., 1998; Itano et al., 2003),
maximizing the surface area for presentation of such antigens. The networked
arrangement of DCs positions them efficiently to transfer antigen transfer from one APC
to another by releasing exosomes or apoptotic bodies (Inaba et al., 1998; Thery et al.,
1999). If antigen is distributed from one migrating cell to several resident cells, the
antigen-presenting surface area expands as the local concentration of pMHC decreases,
increasing the likelihood of detection by a migrating T cell.
As dendritic cells are evenly dispersed throughout the T cell area, the random
walk of T cells maximizes their ability to scan antigenic space (Mempel et al., 2004;
Miller et al., 2003; Miller et al., 2002). The substrate for the DC network is formed by
fibroblastic reticular cells, and is induced by contacts with lymphocytes, in a TNF and
LT-dependent manner (Katakai et al., 2004). Interestingly, it was recently shown that T
cell migration is not completely random, but that it is guided by the paracortical FRC
network (Bajenoff et al., 2006). T cells migrate along the fibers, contacting them
upwards of 95% of the time, and change directions only at branching points in the
network; similar results were seen for B cells migrating on FDCs in B cell follicles
(Bajenoff et al., 2006). This provides an interesting explanation for the periodicity in T
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cell velocity observed by Miller et al. (Miller et al., 2003). It was observed that T cell
velocity has rhythmic peaks at ~2 min intervals, which can now be explained as a T cell
choosing a fiber to crawl on, crawling a distance of 15-30 µm, reaching a new branch
point, and pausing to pick a new direction. While the steady-state T cell motility along
this network is a random walk, additional directional cues can be imparted locally by
chemokines secreted from activated DCs, to change the local attractiveness and net
directionality (Castellino et al., 2006). This model is attractive as it explains baseline T
cell movement while permitting additional chemotactic information to be literally layered
on top; variations along these lines have been suggested by von Andrian’s group
(Henrickson and von Andrian, 2007; Mempel et al., 2006a). We further speculate that
DC movement will be found to follow similar patterns – i.e. that migratory DCs move
along the FRC network, changing directions at branch points, until they “settle down”
and fix their position in the FRC network.

Initial stages of priming and tolerance induction are similar
We observed that in both tolerance and immunity, naïve T cells arrested antigenspecifically shortly after leaving HEVs (Figure 4.10; Movies 4.1, 4.4). Tolerized T cells
recovered marginally faster than primed T cells, but both had recovered significantly by
12-18 h (Figure 4.10; Movies 4.3, 4.6).
This similarity in the early stages of T cell antigen recognition is in contrast to the
results obtained by Hugues et al., who saw stable interactions only in priming and not in
tolerance (Hugues et al., 2004). Possible explanations for this discrepancy include their
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use of explanted lymph nodes which lack blood and lymph circulation, and their failure
to image time points less than 8 h post-T cell transfer. Their method for visualizing DCs
– microinjecting the LN with a labeled anti-CD11c antibody and labeling for 3 h ex vivo
at 37 °C – was also nonphysiological and likely to introduce artifact such as LPS
contamination.
The rapid arrest we observed shortly after T cell exit from HEVs also contrasts
with the dynamic early contacts observed by other groups (Mempel et al., 2004; Miller et
al., 2004b). These groups reported that T cells made only transient interactions during
the first 8 h post-transfer, and stable contacts only formed between 8-20 h, with T cells
regaining speed and making transient contacts at later time points. It was suggested that
the early transient DC:T cell interactions changed the T cell activation state, to permit the
subsequent formation of stable, long-lasting contacts. We should note that we started
imaging between 30 and 60 min after T cell transfer, and are therefore unable to rule out
the existence of a short “phase I” of 30 minutes or less duration. Our in vivo calcium
imaging suggests that T cells signal while decelerating, but that T cells do not stop
immediately upon Ca2+ elevation (Figure 5.8; Movie 5.8), consistent with a brief phase I
in which T cell formation of stable contacts is licensed on the order of 30 minutes or less.
Additionally, our imaging and histology data are consistent with other reports showing
that immunization with antigen in CFA results in early antigen-specific retention of T
cells near HEVs (Bajenoff et al., 2003).
Possible explanations for the difference in the length of phase I observed in
various studies include the use of labelled splenic DCs that must migrate from the
injection site to the LN and enter the T cell area before presenting antigen. If migratory
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splenic DCs are not immediately able to form stable interactions with T cells, only
transient interactions will be observed until the DCs are competent to undergo stable
interactions; however, as DCs were observed simultaneously making both stable and
transient contacts, this may not contribute (Mempel et al., 2004). Another possible
explanation is the increased density of pMHC after antigen targeting with -Dec-205,
compared to the relatively small number of DCs carrying peptide that migrate to the LN.
DCs that have migrated from the periphery, carrying pMHC, are relatively rare,
comprising approximately 1% of DCs in the LN. LN resident DCs, on the other hand,
compose the majority of LN DCs, and after antigen delivery with -Dec-OVA
antibodies, over 50% of DCs express Ova pMHC (Bonifaz et al., 2004).
If T cells do not immediately arrest upon initiation of TCR signalling but must
integrate the signal up to a threshold, T cells that are integrating these signals will first
make serial contacts with DCs before forming stable interactions: while signals are being
integrated, they will make serial contacts, and once this threshold is reached, stable T
cell:DC conjugates will form. This is exactly what was observed and termed phases I and
II, respectively (Mempel et al., 2004). We suggest that the high density of pMHC after
targeting with -Dec-Ova lets T cells rapidly accumulate enough TCR signal to reach the
threshold for prolonged interactions: within 30 min of LN entry, T cells had arrested on
-Dec-Ova targeted DCs, as compared to the 8 hours required for stable contacts to form
on LN migrant DCs (Mempel et al., 2004). We further suggest the general principle that
the amount of pMHC available to T cells may influence the speed with which T cells
arrest and form stable interactions with DCs – that is, the duration of phase I.

132

It is fairly evident that the number of DCs that can present a given antigen will
vary depending on how that antigen has reached the LN. Soluble antigen rapidly drains
to the LNs and is quickly presented by large numbers of LN DCs (Itano et al., 2003). In
addition, in the steady state, self antigens from dead cells and serum proteins are
continually picked up, processed, and presented by large numbers of resident DCs (Inaba
et al., 1997; Inaba et al., 1998; Scheinecker et al., 2002). It should also be noted that not
all pathogens are carried by DCs into the LN - any blood-borne virus or microbe, for
instance, will rapidly be delivered systemically. It thus seems likely that in conditions of
immunity or tolerance, T cells will encounter varying numbers of antigen-presenting
DCs; we therefore suggest that the kinetics of the initial T cell-DC interaction will
depend on the relative frequency of antigen-positive DCs. Further work by von
Andrian’s group supports our earlier speculations: they extended their earlier intravital
imaging by varying the density of pMHC on DCs, and the number of DCs presenting
antigen in the LN, and observed that as the number of dendritic cells presenting antigen,
and the density of antigen on the DC surface increased, the duration of phase I decreased
(Henrickson et al., 2008). This is consistent with our earlier hypothesis that T cells
integrate TCR signals up to a certain threshold, at which point they are licensed to form
stable contacts with DCs.
In conditions of both tolerance and immunity, we occasionally observed T cell
swarming and clustering (Movie 4.7), but the relative rarity with which clusters were
observed was not surprising, as large numbers of DCs present antigen after targeting with
-DEC-Ova (Bonifaz et al., 2004; Hawiger et al., 2001), and the number of T cells in
each cluster is inversely proportional to the number of antigen-presenting DCs (Bousso
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and Robey, 2003).
In some cases, we observed T cells arrested in not in contact with EYFP+ DCs
(Movie 4.8); we feel that the likeliest explanation is that some DC processes are too thin
to be visualized by MPLSM. Other possible explanations are insufficient EYFP
expression in some Dec-205+ cells of the CD11c-EYFP mouse, or antigen transfer to
YFP-low DCs. One further possibility is pMHC presentation by non-DCs: It was
recently shown that LN stromal cells can present pMHC and activate T cells; although
this remains controversial, if CD11c- cells can present Ova pMHC to T cells, it would
follow that T cells could arrest on the antigen-presenting stromal cells (Lee et al., 2007).
We should also note that these possibilities are not mutually exclusive.
It has been argued that delivering antigen systemically is less representative of
physiological antigen presentation than is subcutaneuous inoculation with exogenously
labeled DCs and LPS. This is in fact debatable – the exogenous DCs that are introduced
are not identical to the dermal DCs and Langerhans cells that carry pathogens to the LN.
It is not clear whether splenic DCs, proliferating rapidly due to Flt3L overstimulation,
then purified and injected into the periphery have similar migratory characteristics,
antigen-handling behavior, or responses to pathogens as the endogenous dermal DCs and
Langerhans cells. We observed that exogenous CFP-expressing DCs gradually
incorporated into the paracortical DC network and grew to behave like endogenous DCs
over time (Figure 3.7; Movie 3.16), but we were unable to make direct comparisons with
endogenous migratory cells. It seems unlikely that the kinetics of their immigration and
incorporation into LN DC networks does not differ from that of splenic DCs after
purification.
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Significant heterogeneity in cell behavior exists across the LN; it has been
observed by several groups that superficial cells generally move more slowly than deep
cells (Huang et al., 2004). Our observations, however, do not reflect this finding; we
speculate that it may be due to enhanced phototoxicity in shallow regions of the LN. It is
thus important to compare cells within the same imaging field, to minimize non-specific
effects on the motility of observed cells; ideally, speeds can be normalized to that of
control cells in the same field.
Data we have not yet prepared for publication suggests that adjuvant delivery
leads to a late antigen-independent slowing of T cells. When agonistic -CD40 antibody
was injected concurrently with -DEC-Ova, both specific and non-specific cells slowed
down, beginning 15-18 h after T cell transfer, and persisting for two to three days. This
corresponds with the upregulation of adhesion molecules on DCs, B cells and stromal
cells in lymphoid tissues reacting to inflammation (Dustin et al., 1986), as well structural
changes in the lymph node as it begins to swell (Katakai et al., 2004). It is thus unclear
whether this reflects a purely physical effect due to compression and increased cell
number, increased “stickiness” of the DC and stromal surface as they activate in response
to inflammatory cytokines, or some combination thereof. It is tempting to speculate that
this late antigen-independent adjuvant-induced slowing is a correlate of “signal 2”, the
presence or absence of which leads to priming or tolerizing responses, respectively
(Bretscher and Cohn, 1970; Janeway, 1989).
We found that the early stages of tolerance and immunity are characterized by
similar early T cell arrest near HEVs, with movement recovering to normal by 18 hours.
This is consistent with our findings that T cell activation, proliferation, and responses to
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antigen in vitro were similar in the first 3 d of tolerance and priming. Additionally, this is
corroborated by results showing that T cells can be rescued from deletion 3 d after
antigen exposure if transferred to an antigen-free environment (Redmond et al., 2003).
We suggest that the early stable DC:T cell interactions that can occur in both tolerance
and immunity do not determine commitment to tolerance or immunity; we speculate that
cellular fate commitment to priming or tolerance occurs later as T cells dynamically
contact DCs.

pMHC potency, Ca2+, and the dynamics of DC:T cell interactions
We have evaluated how TCR affinity for pMHC affects T cell functional
responses and migration patterns in LNs in steady-state conditions. High-potency APL
induced rapid deceleration of antigen-specific T cells, T cell proliferation, trapping within
LNs, and anergy (Figure 5.5; Movie 5.1). Medium-potency APL did not alter T cell
motility, but induced a small amount of T cell proliferation and IFN- production,
significant T cell trapping, and a robust anergy (Figure 5.5; Movie 5.2). Low-potency
APL did not alter T cell motility or induce T cell proliferation, but induced anergy and T
cell trapping within LNs (Figure 5.5; Movie 5.3).
All of the APLs tested bind to I-Ek with similar affinity (Lyons et al., 1996;
Rogers et al., 1998), all were delivered via -Dec-205 antibodies, and all induced similar
levels of CD69 upregulation and CD62L downregulation (Figure 5.3). We therefore
conclude that the lack of T cell stopping in response to medium- and low-potency APLs
was not due to reduced pMHC formation or an inability of T cells to detect these APLs in
vivo; the absence of T cell arrest is due to the inability of medium- and low-affinity TCR
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ligands to elevate T cell Ca2+ levels (Figure 5.8). Notably, medium- and low-affinity
APLs still effectively induced LN T cell trapping and anergy (Figure 5.4, 5.5),
demonstrating that these downstream T cell behaviors are independent of Ca2+ elevation
or cellular dynamics.
Since some studies of T cell:DC interactions reported an early, dynamic “phase I”
before the formation of stable interactions (Mempel et al., 2004; Miller et al., 2004b), we
imaged between 6-12 h after T cell transfer, a time frame consistent with reports of an
early dynamic phase. We found no effect of medium- and low-affinity pMHC at either
early or later time points (Figure 5.5), demonstrating that T:DC interactions at all time
points do not determine T cell fate.
Because T cell arrest is necessary for immunological synapse formation, the
absence of T cell arrest in response to medium- and low-potency antigens indicates that
immunological synapse formation is not required for the induction of tolerance in vivo.
The medium-potency APLs did not generate sufficient intracellular Ca2+ to mediate cell
stopping, but did lead to low levels of proliferation, LN trapping, and anergy. This is
consistent with reports of low-avidity pMHC sufficient to induce proliferation without
immunological synapse formation in vitro (Cemerski et al., 2007). Additionally, in vitro
models have shown sequential transient, mobile DC:T cell interactions in cultured ECM
(Gunzer et al., 2000; Gunzer et al., 2004).
Steady-state presentation of medium- and low-potency throughout the DC
network leads to T cell tolerance without antigen-specific arrest on DCs, although T cells
were sequestered antigen-specifically for 2-3 days in LNs. Our results show that TCR
affinity for pMHC determines the dynamics of DC:T cell contacts in vivo, which is
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independent of CD69 upregulation and CD62L downregulation. CD69 was recently
shown to be a negative regulator of sphingosine-1-phosphate receptors, and CD69
upregulation prevents lymphocyte egress from LNs (Matloubian et al., 2004; Shiow et al.,
2006). Thus, although T cells responding to medium- and low-affinity pMHC antigens
under conditions that induce anergy do not arrest, they remain in the antigen-presenting
LN and continue to scan the DC network for 48-72 h. This prolonged exposure to
antigen ensures that T cells that recognize even low-affinity self-pMHC will have
sufficient antigenic contact to integrate many low-level signaling events involving
hundreds of T cell:DC interactions, which is especially important for self antigens with a
restricted range of expression (Iezzi et al., 1998; Lindquist et al., 2004; Miller et al.,
2004a).

Dynamics of germinal centers in vivo.
Germinal centers are physically open structures that are continually scanned by
recirculating B cells; the germinal center – as is the entire B cell follicle – is more
dynamic than had previously been appreciated. Strikingly, naïve B cells enter and pass
through GCs relatively unimpeded, indicating that B cells can enter germinal centers
without participating in germinal center reactions, and that the presence of a B cell in the
germinal center in no way indicates that it is participating in the GC reactions. GC B cells
are distinguishable from follicular B cells and plasmablasts by their location,
morphology, and restricted motion within the GC (Figure 6.4; Movies 6.1, 6.2). In
contrast to naïve B and T cells, which arrest after encountering high-affinity antigens
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presented by DCs, GC B cells decelerate and make longer contacts with FDC-M1+ cells,
but rarely stop for prolonged periods of time (Figure 6.6; Movie 6.5) (Mempel et al.,
2004; Miller et al., 2004b; Qi et al., 2006; Shakhar et al., 2005). We propose that the
selection of GC B cells is governed by multiple dynamic interactions, and note that this
resembles T cell anergy induction by medium- and low-affinity antigens (Skokos et al.,
2007).
Affinity maturation is achieved during the germinal center reaction through
repeated rounds of proliferation and selection on the basis of affinity (MacLennan, 1994).
We have shown that B cells can join an ongoing GC reaction if their affinity is high
enough for them to outcompete the extant cells in the GC (Figure 6.7). Since naïve B
cells migrate for 12-18 h in a given LN follicle before exiting and recirculating to other
LNs, and since 30% of follicular B cells contacted an FDC-M1+ cell, even assuming
some selection bias in the choice of imaged regions, essentially all follicular B cells will
interact with antigen displayed on FDCs in any GC-containing follicle. As GCs last for 23 weeks, with B cells entering LN follicles at random and moving almost entirely along
stromal cell processes, particularly FDCs (Bajenoff et al., 2006), a significant fraction of
all circulating B cells will be exposed to antigen in any given GC; correspondingly, a
significant fraction of B cells within a GC at any given moment will not have descended
from the founder B cells. This, although initially surprising to us, is consistent with a
single-cell analysis of human GCs that found numerous B cells with unmutated and
unrelated antibody genes in tonsillar germinal centers (Kuppers et al., 1993). Continuous
B cell scanning thus ensures that a significant fraction of the entire B-cell repertoire is
exposed to antigen trapped on FDCs, permitting rare high-affinity cells not present in the
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LN when the GC first developed to participate in the GC reaction. This also suggests that
recirculating memory B cells may be able to join and participate in GC reactions –
effectively letting any antibody response compete with the memory response to the same
antigen.
The observation that both B cells and antigen can join an existing GC suggests a
mechanism for intermolecular epitope spreading: a GC forms appropriately in response to
a pathogenic stimulus, and a second antigen is trapped on immune complexes on FDCs in
the GC. As B cells scan this GC, any cells that recognize the second antigen can be
recruited into the GC reaction in a Th-dependent manner.
GC B cells are specifically retained inside the light or dark zone, with
contributions from chemokine receptors CXCR4 and CXCR5 (Allen et al., 2004), and
transit from one zone to the other in approximately 18 h. We observed approximately
equal proportions of cells migrating from one zone to the other, indicating that cells are
not proliferating in one compartment and being selected in the other (Figure 6.5). This is
still consistent with a GC reaction composed of successive rounds of proliferation and
selection, as long as proliferation and/or selection can occur in either zone.
Our results are similar to those observed in a paper that came out shortly before
ours (Allen et al., 2007); Allen et al. observed that the GC was a dynamic structure, with
GC B cells transiting between light and dark zones, and decelerating but not arresting on
FDCs. Cell proliferation and apoptosis was found in both zones; imaging of T cell help
revealed predominantly short interactions, leading them to propose that T cell help is one
of the limiting factors for which newly mutated B cells compete (Allen et al., 2007). A
third paper was published shortly after ours, and found a similar frequency of cells
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transiting directly between light and dark zones, but claimed that most cells do not transit
directly between light and dark zones, instead taking an indirect path via the outer zone
(Hauser et al., 2007). It is difficult to directly compare frequencies among different
studies, as the cells are typically imaged for only 30 minutes, with many cells moving in
and out of the field, which is usually too small to capture an entire GC in all three
dimensions. An alternative explanation of the observation that most cells do not
constantly migrate directly from one zone to another might simply be that the cells need
to spend half a generation time (~3-5 hours) in one zone before becoming licensed to
transit into the other zone; cells that approach the border before they are prepared to cross
it would turn away, leading to tracks that appear to enter the outer zone. As the duration
that B cells spend in one zone is significantly longer than the time it takes a B cell to
transit across one zone and enter the other – 100 µm zone diameter, with a median
displacement rate of 2 µm /min, yields a 50 minute transit time – this indicates that the
velocity of B cells is not the limiting step in DZ-LZ transit. Therefore, most GC B cells
will approach the DZ/LZ border many times before they are licensed to cross it, and as
the cells turn away, this will lead to cell tracks and net cell movement vectors at the
DZ/LZ border in the direction of the outer zone. In any case, it should be emphasized
that all studies have observed that the GC reaction is dynamic, with cells transiting either
directly or indirectly between zones, and that proliferation and selection are not rigidly
segregated into the DZ and LZ, respectively.
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General principles in the cellular dynamics of antigen recognition
The T cell antigenic search algorithm is largely driven by random motility along
the FRC fibers that underlie a network of probing dendritic cells (Bajenoff et al., 2006;
Mempel et al., 2004; Miller et al., 2003). We have shown that migrating DCs distribute
themselves throughout the LN before settling in a fixed location among the LN-resident
DC network, and propose that the FRC fibers serve as a substrate for motility and
guidance for migrating DCs as they do for T cells.
We have shown that the in vivo dynamics of T cell antigen recognition depend on
pMHC potency; as discussed above, considerable evidence suggests that pMHC density
affects the in vivo cellular dynamics as well, which may explain some of the differences
observed (Mempel et al., 2004; Miller et al., 2004b; Shakhar et al., 2005). We propose
that T cell antigen recognition integrates both pMHC density and pMHC potency in
reaching the thresholds for stable conjugate formation, Ca2+ signaling, and proliferation,
but not T cell fate determination, which is independent of pMHC density or potency.
Further work by the von Andrian group supports our hypothesis that T cell signaling
integrates pMHC potency and pMHC density in forming stable contacts (Henrickson et
al., 2008).
Our results have shown that prolonged interactions are not necessary for T cell
fate determination or for continued GC B cell proliferation during GC reactions. This is
additionally consistent with the observations that prolonged Treg:DC or Treg:CTL
interactions are infrequently observed in Treg-mediated suppression (Mempel et al.,
2006b; Tang et al., 2006), T cell help during GC reactions (Allen et al., 2007), or CD8+ T
cell killing (Purbhoo et al., 2004). Although prolonged interactions are observed in the T
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cell response to high-affinity antigens (Mempel et al., 2004; Miller et al., 2004b; Shakhar
et al., 2005; Skokos et al., 2007) and to T cell help early in the B cell response (Okada et
al., 2005), there appear to be relatively few cell:cell interactions characterized by stable
contact formation in vivo. As stable contact formation is necessary for immunological
synapse formation, this suggests that immunological synapses are dispensable for most
cell:cell interactions; the transmission of immunological information in vivo seems to
occur largely through relatively short-lived interactions. Our close collaborator Mike
Dustin recently introduced the term “kinapse” to describe a mobile cell:cell contact that
permits the exchange of information (Dustin, 2008). As more methods for imaging
functional responses and signaling become available, it will be possible to study in more
detail how signaling at the kinapse leads to changes in cellular behavior and function.
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APPENDIX: MOVIE LEGENDS
Movie 3.1. Anatomic location of EYFP+ DCs within the LN. Z-stack of two-photon
images taken at depths of 0-300 µm through a B cell follicle in the LN of a living mouse.
EYFP DCs are green, adoptively transferred EGFP B cells are false-colored cyan. Four
populations of DCs are visible. Bright extended subcapsular DCs (arrows); dimmer DCs
in a network surrounding the follicle; scattered compact DCs in the follicles (circles) and
an extensive network of DCs in the T cell zone of the paracortex.
Movie 3.2. Reconstruction of EYFP+ DCs within the LN. Three-dimensional
reconstruction of the different DC populations around a B cell follicle based on the data
presented in Movie 3.1. Colors are as in Movie 3.1.

Movie 3.3. Blood flow remains intact during intravital imaging. This and all movies
below, unless noted otherwise, are maximum intensity projections of a 50 µm-thick
volume, accelerated ~300-fold over real time; time elapsed is indicated in minutes:
seconds. Blood vessels were visualized with i.v. injection of 66 kDa TRITC-dextran. The
HEVs (crossing from top left to bottom right), can be distinguished from arterioles
(crossing in the perpendicular direction) based on their irregular epithelium and the
shadows of lymphocytes slowly rolling along it. YFP cellular debris is seen on the middle
left. A mixture of slowly moving and sessile CD11c-YFP cells is seen scattered in the
general area of the HEVs, but not immediately juxtaposed to them. Also seen are CFP
lymphocytes (cyan), which exhibit a tighter morphology than DCs and can reach higher
maximum speeds.

Movie 3.4. Lymph flow remains intact during intravital imaging. Lymphatic vessels
were visualized with subcutaneous injection of 66 kDa TRITC-dextran; afferent
lymphatics were imaged in one XY plane every 400 ms. Regular pulsatile motion is seen,
and the shadows of lymphocytes in the vessel can be observed.
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Movie 3.5. T cell extravasation in the lymph node of a living mouse. T cells (blue,
cyan) are visible moving throughout the vasculature (red), visualized by i.v. injection of
655 nm-emitting quantum dots. Many vessels are partially in contact with dendritic cells
(yellow). A single T cell is visible extravasating in the lower right quadrant, indicated by
an arrow - it appears in the middle of the HEV at 8:11, remains relatively stationary for
ten minutes and moves to the left and up over the next ten minutes.

Movie 3.6. Phototoxicity interferes with dendrite probing and cell migration. Even
before phototoxicity is manifested in cell morphology, it leads to cellular immobility.
Lymphocytes (red) stop moving and DCs (green) stop the probing motions of their
dendrites. The use of both dendrite movement and non-specific T cells as internal
controls permits sensitive detection of damage to the imaging field. In the upper right
corner of the field, which was not affected, both T cell crawling and dendrite probing is
visible.

Movie 3.7. Subcapsular sinus DCs and macrophages. Subcapsular sinus EYFP DCs
(green) navigating among the less mobile macrophages, visualized by their phagocytosis
of subcutaneously injected 66 kDa rhodamine-dextran (red). Note some DCS move
rapidly and directionally.

Movie 3.8. Subcapsular DCs probing movement. At higher resolution, the probing
movement of subcapsular DCs can be better appreciated. Note the characteristic ruffle
shaped extensions of these cells. Dimmer, less motile perifollicular DCs are seen in the
background.

Movie 3.9. T cell zone DCs form an extensive network. EYFP DCs (green) form a
network throughout the T cell zone of the LN. Note that the DCs exhibit extensive
probing movements but show little crawling.

145

Movie 3.10. T cell zone DC network dynamics. A time sequence depicting a twodimensional projection of a 50 µm volume in the interface of the T cell and B cell zones.
The T cell zone is located below and to the left of the B cell follicle. The behavior of
CD11c-EYFP DCs (green) in the network was followed. The great majority of the cells
are laterally stable, exhibiting only probing movement, but occasionally a cell could be
seen repositioning within the network (red circles). Adoptively transferred EGFP B cells
are false-colored cyan.

Movie 3.11. Perifollicular DCs in relation to the LN capsule. A 3-dimensional
reconstruction of a lymph node, showing the spatial relation of the perifollicular network
of EYFP DCs (green) to the fibrous capsule (blue, second harmonics signal from
collagen).

Movie 3.12. Different movement patterns of follicular and perifollicular DCs.
Different behaviors of EYFP DCs (green) and ECFP B cells (cyan) in a B cell follicle
(top right) and the perifollicular network (bottom left). Whereas some crawling
movement is observed in the follicle, the DCs in the perifollicular network appear more
dendritic and mainly probe with their processes.

Movie 3.13. DC clusters observed at the T-B interface. DC clusters (EYFP, green) are
seen in the T-B interface zone. Note cells appearing to join and dissociate from clusters.

Movie 3.14. Z-stack through DC clusters in Movie 3.13. A higher resolution Z-stack
(45 µm deep, at 1 µm intervals) descending through DC clusters in the T-B interface area
seen in Movie 13. Each cluster is made up of numerous tightly apposed DCs enveloping
lymphocytes.

Movie 3.15. The behavior of DC clusters in the T-B interface zone. Cluster position
was stable for the duration and remained the same when the area was imaged again 4
hours later. DCs can be seen joining (blue circles) or leaving (red circles) the cluster. The
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shadows of lymphocytes can be seen drawn into the clusters enveloped in DC processes
(yellow circles).

Movie 3.16. Resident LN DCs vs. transferred mature DCs of splenic origin.
Transferred ECFP+ DCs (cyan), immunomagnetically purified from the spleen of a
mouse treated with a FLT3-L-secreting tumor are seen here moving among resident
CD11c-EYFP cells (yellow). The sequence was recorded at a depth of 180-230 µm 48 h
after cell transfer. In this particular field, transferred cells crawled slightly faster than
residents. Most of the movement consists of process probing, with cells occasionally
flowing their soma and nucleus into one of the processes. To emphasize cell morphology
and dynamic probing of migrant DCs, the CFP channel is shown alone on the right.
Movie 3.17. DC Intravasation into HEV. EYFP+ DCs (green) are visible near blood
vessels (red), visualized by injection of 655 nm-emitting quantum dots; ECFP+ (blue) and
EGFP+ (cyan) lymphocytes move around the T cell area. In the upper right corner, a
YFP-expressing DC enters the HEV in the first ten minutes, gradually detaches from the
wall, and is swept away at 19:24.
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Movie 4.1. Tolerizing interactions 1-6 h after T cell transfer. Antigen-specific T cells
(orange) move more slowly than non-specific T cells (red), and are more frequently
arrested on dendritic cells (green). Tracks of specific EGFP-OT-II cells are cyan, and
tracks of nonspecific ECFP-T cells are purple.

Movie 4.2. Tolerizing interactions 6-12 h after T cell transfer. Antigen-specific T cells
(orange) move more slowly than non-specific T cells (red), and are more frequently
arrested on dendritic cells (green). Tracks of specific EGFP-OT-II cells are cyan, and
tracks of nonspecific ECFP-T cells are purple. Antigen-specific T cells are less arrested
than at 1-6 h.

Movie 4.3. Tolerizing interactions 12-18 h after T cell transfer. Antigen-specific T
cells (orange) and non-specific T cells (red) interact with DCs (green) as they move
throughout the T cell area. Tracks of specific EGFP-OT-II cells are cyan, and tracks of
nonspecific ECFP-T cells are purple. Antigen-specific T cells have largely recovered in
speed, but still move slightly slower than nonspecific T cells.

Movie 4.4. Priming interactions 1-6 h after T cell transfer. Antigen-specific T cells
(orange) move more slowly than nonspecific T cells (red) and are more frequently
arrested on DCs (green). Tracks of specific EGFP-OT-II cells are cyan, and tracks of
nonspecific ECFP-T cells are purple.

Movie 4.5. Priming interactions 6-12 h after T cell transfer. Antigen-specific T cells
(orange) move more slowly than nonspecific T cells (red) and are more frequently
arrested on DCs (green). Tracks of specific EGFP-OT-II cells are cyan, and tracks of
nonspecific ECFP-T cells are purple. EGFP-OT-II cells are equally arrested at 6-12 h as
they are at 1-6 h after transfer.

Movie 4.6. Priming interactions 12-18 h after T cell transfer. Antigen-specific T cells
(orange) move more slowly than nonspecific T cells (red) and are more frequently
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arrested on DCs (green). Tracks of specific EGFP-OT-II cells are cyan, and tracks of
nonspecific ECFP-T cells are purple. EGFP-OT-II cells have partially recovered in speed,
but are still more arrested than the nonspecific ECFP-T cells.

Movie 4.7. T cell swarming. This phenomenon is relatively rare with antigen targeted to
DEC-205, as compared to cell-bound antigen delivered by a small fraction of APCs in the
lymph node. The swarm seen here is composed of antigen-specific EGFP-OT-II T cells
(orange) and not wild-type ECFP T cells (red).

Movie 4.8. T cell arrest on fluorescent and non-fluorescent dendritic cells. T cell
arrest on EYFP- cells was often observed. This may reflect DCs that express relatively
low levels of EYFP or processes of EYFP+ DCs too thin to be visualized by multiphoton
microscopy. The rightmost T cell is seen contacting an EYFP+ DC, then detaching and
arresting nearby, possibly on the surface of a non-fluorescent APC.
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Movie 5.1. T cells arrest upon recognizing the high-potency pMHC L98A. Twophoton visualization of T cell motility in a representative lymph node of a CD11c-EYFP
mouse injected 6-9 hours earlier with the high-potency construct -Dec-L98A. Shown is
a maximum intensity projection of a 50 µm-thick volume. Antigen-specific AND T cells
which express ECFP (pseudo-colored red) move more slowly than non-specific T cells
(EGFP, pseudo-colored orange), and are more frequently decelerated on dendritic cells
(EYFP, pseudo-colored green). The sequence is repeated with tracks of specific ECFPAND cells indicated in cyan, and tracks of nonspecific EGFP-T cells shown in magenta.
Time elapsed is in minutes: seconds.

Movie 5.2. T cells do not arrest upon recognizing the medium-potency pMHC
Y97K. A representative lymph node of a mouse similarly treated with the mediumpotency -Dec-Y97K, visualized as in Movie 5.1. Antigen-specific T cells move as fast
as non-specific T cells, and interact similarly with dendritic cells.

Movie 5.3. T cells do not arrest upon recognizing the low-potency pMHC T102L.A
representative lymph node of a mouse similarly treated with the low-potency -DecT102L, visualized as in Movie 5.1. Antigen-specific T cells move as fast as non-specific
T cells, and interact similarly with dendritic cells.
Movie 5.4. In vitro Ca2+ flux in response to unloaded GPI–I-Ek. Calcium signaling and
migration on glass supported bilayers. In vitro activated AND T cells were labeled with
Fura-2 and were imaged every 15 seconds. The images on the left are pseudo-colored
ratio images representing Fura-2 ratios, such that purple corresponds to a ratio of 0.2 and
red corresponds to a ratio of 1.0. The images on the right are generated using Interference
Reflection Microscopy and the dark areas represent cells making contact with the bilayer
substrate. The bilayer in this sequence contains 50 molecules/ µm2 of unloaded GPI–I-Ek
and 300 molecules / µm2 of GPI–ICAM-1. Only the cells making contacts are quantified.
Scale bar equals 10 µm.
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Movie 5.5. In vitro Ca2+ flux in response to L98A. Calcium signaling and migration on
glass supported bilayers. In vitro activated AND T cells were labeled with Fura-2 and
were imaged every 15 seconds. The images on the left are pseudo-colored ratio images
representing Fura-2 ratios, such that purple corresponds to a ratio of 0.2 and red
corresponds to a ratio of 1.0. The images on the right are generated using Interference
Reflection Microscopy (IRM) and the dark areas represent cells making contact with the
bilayer substrate. The bilayer in this sequence contains 10 molecules/ µm2 of L98A
loaded GPI–I-Ek and 300 molecules / µm2 of GPI–ICAM-1. High calcium fluxes are
observed as soon as cells make contact, and calcium levels are sustained for long periods
of time. Only the cells making contact are quantified. Scale bar equals 10 µm.
Movie 5.6. In vitro Ca2+ flux in response to Y97K. Calcium signaling and migration on
glass supported bilayers. This movie was acquired using similar conditions as in Movie
5.5, except that the bilayer contains 10 molecules/ µm2 of Y97K loaded GPI–I-Ek and
300 molecules / µm2 of GPI–ICAM-1. Only the cells making IRMs are quantified. Scale
bar equals 10 µm.
Movie 5.7. In vitro Ca2+ flux in response to T102L. Calcium signaling and migration on
glass supported bilayers. This movie was acquired using similar conditions as in Movie
5.5, except that the bilayer contains 10 molecules/ µm2 of T102L loaded GPI–I-Ek and
300 molecules / µm2 of GPI–ICAM-1. Only the cells making contacts are quantified.
Scale bar equals 10 µm.
Movie 5.8. In vivo Ca2+ flux in response to -Dec-L98A. Confocal visualization of
Ca2+ response in a representative lymph node of a B10BR mouse injected 5 hours earlier
with the high-potency construct -Dec-L98A. Intravital images were acquired between 0
and 2 h after cell transfer. Shown is a maximum intensity projection of a 20 µm-thick
volume. Blood flow is visualized by Alexa-647 70 Kd dextran administration (pseudocolored blue). Antigen-specific AND T cells labeled with CMRA (red). Cells were colabeled with Fluo-4, a calcium sensitive dye (green). Increases in Fluo-4 fluorescence
indicate high Ca2+ levels. Shown here, high Fluo-4 fluorescence intensity occurs as AND
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T cells exit the blood vessel, appears as yellow/orange when overlapping with the
cytoplasmic dye.
Movie 5.9. In vivo Ca2+ flux in response to -Dec-Y97K. Confocal visualization of
Ca2+ response in a representative lymph node of a B10BR mouse injected 5 h earlier with
the medium-potency construct -Dec-Y97K. As described in Movie 5.8.

Movie 5.10. In vivo Ca2+ flux in response to -Dec-T102L. Confocal visualization of
Ca2+ response in a representative lymph node of a B10BR mouse injected 5 h earlier with
the low-potency construct -Dec-T102L. As described in Movie 5.8.
Movie 5.11. In vivo Ca2+ flux in untreated control. Confocal visualization of Ca2+
response in a representative lymph node of a B10BR mouse used as untreated control. As
described in Movie 5.8.
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Movie 6.1. Overview of a germinal center. Intravital imaging of a GC in the inguinal
LN, with collagen fibers in the capsule visible in blue, EGFP+ B1-8hi B cells in green, and
FDCs in red, labeled by s.c. injection of Alexa 647-labeled FDC-M1 antibody. The GC
is in the center of the field, surrounded by the B cell follicle; plasmablasts are visible in
the medulla in the lower half of the field.

Movie 6.2. Dynamics of GC B cells. Intravital imaging of a GC in the inguinal LN 6 d
post-boost with NP, with ECFP+ nontransgenic control B cells in blue, EGFP+ B1-8hi B
cells in cyan, and FDCs in red, as in Movie 6.1. Note that GC B cells are largely
restricted to the center of the GC, while control B cells move freely.

Movie 6.3. Dynamics of GC B cells without antigen boost. Intravital imaging of a GC
in the inguinal LN, without antigen boost, with ECFP+ nontransgenic control B cells in
blue, EGFP+ B1-8hi B cells in cyan, and FDCs in red, as in Movie 6.1. Both
nontransgenic and B1-8hi B cells move freely in the absence of NP antigen.

Movie 6.4. GC without FDC labeling. Intravital imaging of a GC in the inguinal LN 6
d post-boost with NP, with ECFP+ nontransgenic control B cells in blue, and EGFP+ B18hi B cells in cyan. Note that GC B cells are largely restricted to the center of the GC,
while control B cells move freely.

Movie 6.5. Dynamics of B1-8hi B cell:FDC contacts. Intravital imaging of a GC in the
inguinal LN 6 d post-boost with NP, with ECFP+ nontransgenic control B cells in blue,
EGFP+ B1-8hi B cells in green, and FDCs in red, as in Movie 6.1. The track of a B1-8hi B
cell is denoted in green, repeatedly making brief contacts with the FDC.
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Movie 6.6. Dynamics of nontransgenic B cell:FDC contacts. Intravital imaging of a
GC in the inguinal LN 6 d post-boost with NP, with ECFP+ nontransgenic control B cells
in blue, EGFP+ B1-8hi B cells in green, and FDCs in red, as in Movie 6.1. The track of a
nontransgenic control B cell is denoted in blue, and is not notably associated with FDCs.
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